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Preface 
This dissertation is submitted in partial fulfilment of the requirements for 
obtaining the degree of Doctor of Philosophy. The thesis consists of an 
introduction summarising the literature relevant for the project, based on studies 
at the crossing point between clinical microbiology, innovative biotechnology, and 
experimental animal research.  
 
The PhD project was carried out between July 2012 and June 2016 at Department 
of Clinical Microbiology, Aalborg University Hospital and at the Center for 
Microbial Communities, Department of Chemistry and Biosciences, Aalborg 
University. The project was partly funded by a grant for the project “Prosthesis: 
Reduction of Infection and Pain” (PRIS) from the Danish Agency for Science, 
Technology, and Innovation. Additionally, Arla Foods Ingredients Group P/S 
(Denmark) funded part of the in vivo study. 
 
First and foremost, I would like to express my deepest gratitude to my two 
supervisors: Henrik C. Schønheyder and Trine Rolighed Thomsen for giving me the 
opportunity to work with clinical microbiology in such interesting explorative 
settings. Thank you Henrik for always dedicating 110% to the work and the 
interesting discussions of movies not to watch. Thanks, Trine for you unfailing 
optimism and good discussions, it is fantastic to work with you. 
 
I would like to thank everyone at Department of Clinical Microbiology, Aalborg 
University Hospital, for creating a good working environment and helping a PhD-
student a lot when needed. In particular, Lena Mortensen for training me in the 
art of culture based clinical microbial diagnostic and covering for me when the 
PRIS project was running. In Department of Orthopaedic Surgery I would like to 
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thank the surgeons and especially Vesal Khalid, without whom no patients would 
have been included. 
 
I would also like to thank everyone in the Environmental Biotechnology group for 
creating an inspiring environment. My thanks go especially to Yijuan Xu for 
constructive discussions and great collaboration during the project and to the 
technicians Jane Ildal, Susanne Beilidt and Marianne Svensson for always being 
helpful in the lab. 
 
I would like to express my appreciation to the partners in the PRIS project for good 
collaboration, particularly Jan Lorenzen and Peter Lüttge Jordal at the Danish 
Technological Institute, and Santina Castriciano, Copan, Italia. 
 
Last but most important I would like to thank the most important persons in my 
life, Mads and Rosa, for your understanding and patience during the final work-up 
and for putting the things into perspective. 
 
I hereby declare this is my original work. 
 
Lone Heimann Larsen 
August 2016 
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English summary 
More and more people are living with an implant such as pacemakers and joint 
prostheses. In Denmark the annual number of surgical procedures for insertion of 
a primary hip or knee prosthesis is approx. 18,000, and the risk of infection 
following primary implantations is 0.6-2% and higher after revision surgeries. The 
infection is often located as a bacterial biofilm on the implant or in close proximity 
to the implant. Consequently, the diagnosis of infection can be a challenge. Biofilm 
infections are often difficult to diagnose due to the adherence of bacteria to the 
implant. A surgical intervention is therefore often necessary in order to obtain 
specimens from relevant sites. A second obstacle is the low growth rate of 
bacteria in biofilm and the need to ‘awake’ the persisters, requirements that are 
not necessarily met by standard culture methods. As a consequence there is a risk 
of false negative culture reports. By investigating new diagnostic methods, both 
culture or molecular based, further improvement may be obtained.  
 
The aim of this PhD project was to characterise the clinical diagnostic challenge of 
prosthetic joint infections (PJI) and to evaluate well-established diagnostic 
methods together with explorative methods for investigation of the microbial 
diversity. A third aim was to get insights from a guinea pig Staphylococcus aureus 
biofilm infection model using transcriptomics in order to reveal potential targets 
for new therapeutic interventions in implant related infections. 
 
The foundation of clinical diagnosis for PJI was discussed, including the 
contribution of specimen logistic and transport media together with alternative 
methods for revealing a possible infection: PCR/ESI-TOF-MS (IRIDICA), 
fluorescence in situ hybridization (FISH) and sequencing techniques. 
In a large clinical study of prosthesis related problems, the diagnostic of PJI was 
investigated and the contribution of different specimens obtained in parallel was 
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evaluated. All specimen types investigated were evaluated both by culturing and 
16S rRNA sequencing. The optimal specimen set was found to be culturing of a 
combination of joint fluid, sonication fluid from the prosthesis component, and 5 
soft tissue biopsies.  
 
In addition to revealing the infectious organism, the insight from a guinea pig 
biofilm implant infection model revealed via transcriptomics that the gene 
expression profile was remarkably similar despite a different course of infection, 
and that the gene expression profiles also concorded well with a human PJI 
infection being the source of the strain used for inoculation. The data shows 
anaerobic pathways to be predominating and pyruvate metabolism in particular. 
Different strategies were activated in order to handle the acidic environment, and 
this may be a vantage point for future treatment strategies for S. aureus infection. 
 
As a conclusion, the improvement of the diagnosis and treatment of PJI depends 
foremost on the recognition of the microorganism/s. No single specimen type or 
diagnostic method has yet been proven to cover the entire spectrum of PJI 
patients, but by using a specimen collection the coverage improved. Secondly, 
new treatment strategies are warranted, therefore better understanding of how 
microorganisms behave in biofilm infections can contribute in that respect. 
Findings from the guinea pig model revealed remarkable similar gene expression 
profiles, but different strategies in regulation of stress responses were observed. 
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Dansk resume 
Flere og flere mennesker lever med medicinske implantater som pacemakere og 
ledproteser. I Danmark bliver der årligt foretaget ca. 18.000 primære hofte- og 
knæalloplastikker med en risiko for infektion i leddet på 0,6-2% som følge af 
operationen. Infektionen er oftest lokaliseret som en bakteriel biofilm på 
protesekomponenterne eller i tæt relation til protesen. Som en konsekvens heraf 
kan det være svært at identificere den bakterielle biofilminfektion. Et operation er 
derfor ofte nødvendig for at tage prøver til diagnostik fra relevante steder. En 
anden udfordring er den lave vækstrate som bakterier i biofilm har fænotypisk; 
det er ikke optimal i forhold til traditionel dyrkningsbaseret diagnostik, og kan føre 
til falsk negative dyrkningsresultater. Ved undersøgelse af mulige nye diagnostiske 
metoder, både dyrkningsafhængige og -uafhængige metoder kan vi måske finde 
nye strategier til at forbedre den nuværende diagnostik. 
 
Formålet med denne afhandling er at karakterise de diagnostiske udfordringer i 
klinikken i forbindelse med ledprotese infektioner (PJI) samt at evaluere 
veletablerede diagnostiske metoder sammen med mere eksplorative metoder 
med det formål at udforske den mikrobiologiske diversitet hos de inficerede 
patienter. Ydermere vil en marsvin Staphylococcus aureus infektionsmodel med 
indsatte fremmedlegemer give indblik i bakteriernes metabolisme ved hjælp af 
transcriptomics og måske afsløre sårbare punkter, som kan bruges i 
behandlingsøjemed. 
 
De grundlæggende elementer for den klinisk mikrobiologiske diagnose af PJI er 
diskuteret, inklusivt bidraget til diagnosen fra prøvelogistik og transportmedier 
samt alternative metoder. De alternative metoder inkluderer PCR/ESI-TOF-MS 
(IRIDICA), fluorescence in situ hybridization (FISH) og sekvenseringsteknikker. I et 
større klinisk studie af ledprotese-relaterede problemer (PRIS projektet) blev 
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diagnosen af PJI evalueret, både med standarddiagnostik og udvidet diagnostik 
med såvel dyrkningsbaserede som dyrkningsuafhængige metoder. Alle prøvetyper 
blev undersøgt med udvidet dyrkning og 16S rRNA sekvensering. Vi fandt, at det 
optimale diagnostiske prøvesæt til patienter med PJI er ledvæske, 
protesekomponenterne og 5 vævsbiopsier. 
 
Oveni afslører indblikket fra marsvinemodellen genekspressionsprofiler, som var 
bemærkelsesværdigt ens for alle infektioner uanset forhistorie, og yderligere viste 
en sammenligning med en human infektion med samme stamme også dette 
mønster. Data viser anaerob metabolisme som dominerende og specielt centreret 
omkring pyruvatomsætningen. Desuden blev påvist flere forskellige strategier 
betinget af et lavt pH and og andre stress responser. Denne information kan være 
væsentlig for fremtidige behandlingsstrategier for S. aureus infektioner.  
 
Forbedringen af diagnose og behandling af PJI må som første prioritet have 
afsløring af den inficerende mikroorganisme. Ingen enkeltstående prøvetype eller 
diagnostisk metode har vist sig at kunne dække hele spekteret af patienter, hvilket 
understøtter vores anbefaling af et prøvesæt til diagnosen frem for en enkelt 
prøvetype. Anden prioritet må være udvikling af nye behandlingsstrategier, hvilket 
kræver et bedre indblik i biofilm infektioner fx fra dyremodeller og analyse af 
genekspressionsprofiler.  Bakteriernes forskellige strategier i forhold til stress 
responset kan vise sig at rumme nye targets for behandling.  
ix 
List of papers  
Included in the thesis 
 
Paper 1 
Larsen, L.H., Lange, J., Xu, Y., and Schønheyder, H.C. (2012). Optimizing culture 
methods for diagnosis of prosthetic joint infections: a summary of modifications 
and improvements reported since 1995. J. Med. Microbiol. 61, 309–316. 
 
Paper 2 
Larsen, L.H., Xu, Y., Simonsen, O., Pedersen, C., Schønheyder, H.C., Thomsen, T.R., 
and PRIS Study Group (2014). ”All in a box” a concept for optimizing 
microbiological diagnostic sampling in prosthetic joint infections. BMC Res. Notes 
7, 418. 
 
Paper 3 
Larsen, L.H., Khalid, V., Xu, Y., Thomsen, T.R., Schønheyder, H.C. and the PRIS 
Study Group. 
Diagnostic value of culture and 16S rRNA sequencing in patients undergoing 
revision surgery for infection of a hip or knee arthroplasty. 
Draft 
 
Paper 4 
Larsen, L.H. Xu, Y, Nielsen, K.L., Schønheyder, H.C., and Thomsen, T.R. 
In vivo gene expression in a Staphylococcus aureus biofilm infection model in 
guinea pigs: Impact of antibiotic treatment with moxifloxacin. 
Draft 
 
Not included papers:  
Xu, Y., Maltesen, R.G., Larsen, L.H., Schønheyder, H.C., Nielsen, P.H., Nielsen, J.L., 
Thomsen, T.R., Nielsen, K.L. (2016). In vivo gene expression in a Staphylococcus 
aureus prosthetic joint infection characterized by RNA sequencing and 
metabolomics: a pilot study. BMC Microbiology DOI: 10.1186/s12866-016-0695-6 
 
Xu Y., Schønheyder, H.C., Larsen, L.H., Laursen, M. B., Ehrlich, G.D., Lorenzen J., 
Nielsen, P.H., Thomsen, T.R., and the PRIS Study Group (2014). Characterization of 
bacterial communities in suspected prosthetic joint infections. In Applications of 
Molecular Microbiological Methods, Editor: T.L. Skovhus, S.M. Caffrey, and C.R.J. 
Hubert, eds. Caister Academic Press), pp. 93-103.  
 
  
xi 
Objective of this PhD study 
 
The overall aim of this PhD project was to investigate and characterise biofilms in 
infections associated with prosthetic joints and to study the response to 
antibiotics in bacterial infection by use of an in vivo experimental animal model.  
The specific goals of the project were: 
 
• To evaluate a highly standardised sampling procedure promoted by pre-
packed boxes with all transport media, containers and request forms 
needed during surgery in patients with a prosthetic joint related problem. 
 
• To identify bacteria by culture-dependent and molecular methods in 
patients with a prosthesis related problem taking advantage of different 
specimen types obtained in multiples from the vicinity of the prosthesis 
following a rigorous protocol and using the pre-packed box.  
 
• To propose an optimal diagnostic specimen set for patients undergoing 
surgery for a prosthesis related problem based on results obtained with 
the highly standardised sampling procedure. 
 
• To investigate the gene expression profile of a biofilm infection exposed 
to antibiotics in vivo using a well characterised foreign body animal 
model.  
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Abbreviation 
CoNS Coagulase negative Staphylococcus spp. 
CFU Colony forming units 
CRP C-Reaktivt Protein 
DRNA Dissimilatory reduction of nitrate to ammonium 
EPS Exopolysaccharide matrix 
ESCMID European Society of Clinical Microbiology and Infectious Diseases 
ESI-TOF-MS  High-performance electrospray ionization time-of-flight mass 
spectrometry 
GC-MS  Gas chromatography coupled to mass spectrometry  
CR-MS Capillary electrophoresis coupled to mass spectrometry 
ICD Implanterbar Cardioverter Defibrillator 
IDSA Infectious Diseases Society of America 
LC-MS Liquid chromatography coupled to mass spectrometry 
MS Mass spectrometry 
ng nanogram 
NGS Next generation sequencing 
NMR Nuclear magnetic resonance spectroscopy 
OUT Operational taxonomic unit 
PJI Prosthetic joint infection  
PCR Polymerase Chain Reaction 
qPCR Quantitative Polymerase Chain Reaction 
THA Total hip arthroplasty 
TKA Total knee arthroplasty 
WGS Whole genome sequencing 
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Chapter 1 Prosthetic joint infections 
Chapter 1. Prosthetic joint infections 
1.1. Background 
More and more people are living with an indwelling medical implant such as 
pacemakers, joint prostheses, and medical pumps. Implants can be an integral part 
of medical or surgical treatment and may either be temporary or permanent.  
Additionally, non-medical implants such as fillers are used extensively in cosmetic 
surgery.  
Implant surgery aims to secure or improve the patient’s health and life-quality, but 
despite aseptic precautions and antibiotic prophylaxis during implantations, 
microbial infection still remains a problem. A complicating infection may have 
serious consequences for the individual patient, including removal of the implant, 
but may also lead to significant societal costs.  
In the US alone, the hospital costs of hip and knee prosthetic joint infections (PJIs) 
were estimated to be $556 million in 2009 involving a total of 7,162 hip and 14,802 
knee prostheses (Kurtz et al., 2012). Data were drawn from the Agency for 
Healthcare Quality and Research Register, which cover up to 20% of US hospitals; 
these estimates did not include costs related to temporary loss of the ability to 
work. In Denmark statistical data are available for specific types of implants, e.g. 
hip and knee prostheses and cardiac pacemakers/defibrillators (Danish hip 
alloplastic register: www.dhr.dk, Danish Knee alloplastic register: www.knee.dk, 
and Danish pacemaker and ICD register: www.pacemaker.dk). However, a general 
overview is difficult to find. In the US a top-11 list has been compiled primarily for 
financial interest (McIntyre, 2011). The annual numbers of hip and knee 
replacements in this list were 230,000 and 543,000, respectively (Table 1). 
In Denmark the annual numbers of primary total hip (THA) and total knee 
arthroplasties (TKA) were 9,410 (revisions: 1,366) and 8,535 (revisions: 1,291) in 
2014 and 2012, respectively (Danish hip alloplastic register, 2015; Danish knee 
alloplastic register, 2013). The risk of infection after a primary arthroplasty is in the 
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range of 0.6-2% and higher after revision surgeries (Dale et al., 2012; Gundtoft et 
al., 2015). 
With a steady increase in the numbers of persons with arthroplasties and a 
continuous rise in life expectancy, more failures due to infection must be foreseen. 
Thus, a better understanding of PJI is warranted in order to improve diagnosis, 
treatment, and prevention. The spectrum of microorganisms and their adaption to 
the foreign body environment are of particular interest. This thesis addresses these 
issues in relation to hip and knee prosthetic infections. 
 
Table 1. Estimates for the eleven most frequent implants in the US (McIntyre, 2011).  
Implants Reporting year Numbers Cost (billion $) 
Implantable cardioverter defibrillators (ICD) 2009 133,000 5.5 
Hip prostheses 2007 230,000 10.5 
Pacemakers  2009 235,000 4.5 
Breast implants, purely cosmetic1 2010 366,000 1.0 
Spinal fusion hardware 2008 413,000 10 
Intrauterine devices NS 425,000 0.3 
Trauma fracture repair 2007 453,000 4.5 
Knee prostheses NS 543,000 12 
Coronary stents 2007 560,000 7.5 
Tympanostomy tubes  2006 715,000 1-22 
Implantable eye lenses (pseudophakos) 2006 2,600,000 8-102 
 
1.2. Infections related to orthopaedic implants 
Prosthetic joints are permanent and a 15-year survival rate of 86% with any 
revision as endpoint has been reported for total hip alloplasties in Denmark 
Chapter 1 Prosthetic joint infections 
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(Mäkelä et al., 2014). The main indications for joint prostheses are arthrosis, 
femoral neck fracture, and inflammatory arthropathies (e.g., rheumatoid arthritis). 
The PJI can either occur as a consequence of contamination during surgery or as a 
consequence of haematogenous spread (Zimmerli, 2014) (for further classification 
see next section). For both types of infection the prosthesis is colonised by bacteria 
(rarely by other types of microorganisms) which adhere to the surface and multiply 
(Zimmerli & Moser, 2012). Some surface materials and areas of the joint prosthesis 
are more readily colonised than others, e.g., stainless steel has been shown to be 
more favourable for bacteria than titanium, and the interface between the 
prosthesis and bone has a higher probability for colonization than the capsule of 
the joint (Bjerkan et al., 2012; Darouiche, 2001).  
For the diagnosis of PJI it is crucial to identify the infecting organism in addition to 
classify the type of PJI (see next section). Until recently there were no 
internationally accepted guidelines for the diagnosis of PJI, and therefore either 
national, regional or even hospital-based criteria have had precedence (Atkins et 
al., 1998; Zimmerli, 2014). Recently, the Infectious Diseases Society of America 
(IDSA) and the European Society of Clinical Microbiology and Infectious Diseases 
(ESCMID) have published guidelines for the diagnosis and treatment of PJI and 
biofilm infections, respectively (Høiby et al., 2015; Osmon et al., 2013). In addition 
to clinical findings (elevated temperature, local inflammation and pain), X-ray 
imaging, and blood biochemistry (sedimentation rate, C-reactive protein (CRP), 
joint fluid leukocyte count), the focus has been on the microbiological diagnosis. 
Joint fluid examination and histopathology have been less consistent elements of 
the diagnosis. Despite the crucial role of identifying causative agents of infection, 
there has been a lack of thorough studies investigating which specimen types are 
most reliable on a routine basis. As a consequence, most of the recommendations 
in the guidelines have been based on expert opinion.  
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1.2.1. Classification of PJI 
PJI has been classified as early (<3months after surgery), delayed (3-24 months 
after surgery), and late (>2 years after surgery), first by Coventry (1975) and later 
modified by Fitzgerald and co-workers (Coventry, 1975; Fitzgerald et al., 1977). The 
classification was based on clinical presentation and level of inflammatory markers, 
and this was later further elaborated by Romanò and co-workers (Table 2) 
(Romanò et al., 2011).  
 
 Table 2. Spectrum of clinical presentation of PJI (modified from Barrett & Atkins, 2014; 
Romanò et al., 2011) 
Early acute 
 
Less than three months after insertion 
 
Warm, swollen, painful, erythematous joint 
 
± Features of systemic sepsis 
Early chronic 
 
Less than three months after insertion 
 
Persistent wound drainage. 
Delayed/late acute 
 
More than three months after insertion 
 
Warm, swollen, painful, erythematous joint 
 
± Features of systemic sepsis 
Delayed/late chronic 
 
More than three months after insertion 
 
Chronic pain ± sinus 
 
Loosening may be apparent on X-ray 
 
Together the early PJIs that are typically exogenous, i.e. acquired during 
implantation or in the period immediately after the surgery via drainage or via the 
cicatrix with coagulase-negative staphylococci (CoNS) and Staphylococcus aureus 
as the major infectious agents (Stefansdottir et al., 2009). Late PJIs can be caused 
both by bacteria introduced during implantation or by dissemination through the 
bloodstream. Infections with a latent period of more than one month are typically 
caused by microorganisms of low virulence, including CoNS and Propionibacterium 
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acnes (Zimmerli, 2014). Fitzgerald found PJI to be haematogenous in patients 
presenting symptoms more than 2 years after insertion without previous 
indications (Fitzgerald et al., 1977) which later are confirmed by a major Swedish 
study (Stefansdottir et al., 2009). Overall for haematogenous PJIs, S. aureus is the 
most common infectious agent followed by streptococci and Gram-negative 
bacteria in that order. 
 
Table 3 Bacterial species causing infection in prosthetic joints in hips and knees. (Larsen et 
al., DraftPaper 3; Stefansdottir et al., 2009; Trampuz et al., 2007)  
Most comon bacteria in PJI Unusual bacteria in PJI 
Staphylococcus aureus 
Coagulase-Negative Staphylococcie 
Streptococcus sp. 
Enterococcus sp. (facalis/faecium) 
Propionibacteium acnes 
Corynebacterium sp. 
 
Escherichia coli 
Pseudomonas aeruginosa 
Enetrobacter sp. 
Salmonella serovar 
Mycobaterium tuberculosis 
Peptostreptococcus sp. 
Dermabacter sp.  
Proteus mirabilis 
Klebsiella pneumonia 
Haemophilus influenza 
 
Peptoniphilus sp. 
Anaerococcus sp. 
Aeromonas sp. 
Bactoides sp. 
 
Typical bacteria in polymicrobial PJI 
 
Coagulase-Negative Staphylococcie  
Staphylococcus auerus 
Enterococcus sp. 
Streptococcus sp. 
Finegoldia magna 
Corynebacterium sp. 
 
 
The proper classification of joint prosthesis-related infection is important from a 
therapeutic point of view: Patients with early infection or a likely acute 
haematogenous PJI with symptoms for less than a month can be treated 
successfully with ‘housecleaning’ (implants being retained) and directed antibiotic 
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treatment, whereas patients with a delayed or chronic infection need to have the 
implant removed as an adjunct to antibiotic treatment (Zimmerli, 2014).  
1.3. Clinical challenges posed by biofilm 
The first descriptions of biofilm infections were published in the early 1980s using 
electron microscopy for visualizing the adherence of bacteria and amorphous 
material to pacemaker electrodes and intravascular implants (Locci et al., 1981; 
Marrie et al., 1982). Based on newer research, biofilm infections have been defined 
by Hall-Stoodley et al. as 
”infections due to aggregated, pathogenic or opportunistic 
microorganisms encased in an exopolysaccharide matrix (EPS)  and 
recalcitrant to host defence mechanisms and antimicrobial treatment” 
(Hall-Stoodley et al., 2012).  
A previous definition of biofilms required an association with a surface, but the 
current definition allows e.g., cystic fibrosis to be included. The main characteristic 
of a biofilm is the aggregation of microorganisms within an extracellular matrix (the 
EPS described above) composed of self-produced macromolecules including 
polysaccharides, nucleic acids, proteins, and lipids plus additional host components 
(Hall-Stoodley & Stoodley, 2009). Biofilms are conceived to be an ancient 
adaptation of the prokaryotic life form for survival in fluctuating and/or extreme 
environments and are hypothesised to be the most natural phenotype for bacteria 
(Hall-Stoodley et al., 2004). 
1.3.1. Pathogenesis of prosthesis-related biofilm 
The biofilm in a implant-related infection can originate from the human skin, either 
from the host or the operating staff during surgery or through haematogenous 
spread (Schierholz & Beuth, 2001). For the biofilm to form, bacteria have to adhere 
to the surface of the implant, called seeding, where it becomes an irreversible state 
over time. The surface material, host macromolecules from plasma (e.g., fibrinogen 
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and fibronectin) and tissues, and the bacterial species and their phenotypes are of 
major importance for the biofilm formation. In addition, physiochemical properties 
of the surrounding environment (access to nutrients, pH, and temperature) impact 
on the growth of the biofilm (Donlan, 2001; von Eiff et al., 2005). After attachment 
to the surface, changes in the bacterial phenotype begin and a maturation of the 
biofilm starts.  
 
 
Figure 1 The process of biofilm formations (Xu, 2014, modified Biofilm structer from MSU 
Center for Biofilm Engineering, P. stoodley & P Dirckx, reprinted with permitision) 
 
Two major benefits of the life in a biofilm are protection against a range of host 
defences and tolerance towards antibiotics. The EPS matrix restricts the diffusion 
of effector molecules like immunoglobulins and complement factors, and this is 
true also for antibiotics. Another protective factor provided by the biofilm is the 
variation of phenotypes in different zones. In dormant zones the metabolic activity 
is low, which mitigates against the bactericidal effect of most antibiotics (Stewart, 
2002; Walters et al., 2003). Within the biofilm a resistant population of bacteria 
referred as ‘persisters’ remain inactive for long periods of time and are the likely 
explanation for relapses even after long periods of time(Conlon, 2014; Lewis, 
2008). 
An additional factor explaining the recalcitrance of biofilm against antibiotic 
therapy is a higher frequency of horizontal gene transfer of resistance and putative 
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virulence genes in biofilm communities compared with a planktonic population 
(Costerton et al., 2005; Fux et al., 2005; Madsen et al., 2012) 
1.3.2. From the patients to the laboratory and back again 
Biofilm infections are often difficult to diagnose due to the adherence of bacteria 
to the implant. A surgical intervention is therefore often necessary in order to 
obtain specimens from relevant sites. A second obstacle is the low growth rate of 
bacteria in biofilm and the need to ‘awake’ the persisters, requirements that are 
not necessarily met by standard culture methods. As a consequence there is a risk 
of false negative culture reports. In order to improve diagnostic accuracy, 
prosthetic components have been handled aseptically and undergone mild 
sonication in order to liberate and revive bacteria from biofilms (Gomez & Patel, 
2011; Hall-Stoodley et al., 2012). This diagnostic procedure seems to be an 
adequate response to the challenge posed by biofilms, but by investigating other 
new diagnostic methods, both culture or molecular based, the diagnostic might be 
further improved (Larsen et al., Draft)Paper 3.  
Failure to detect biofilm bacteria can have significant consequences (Thomsen et 
al., 2011). The frequent polymicrobial nature of biofilm can lead to only partial 
coverage by antibiotic treatment chosen in accordance with results obtained by 
standard cultures and may even lead to mistaking a PJI for a loosening of the 
prosthesis. Besides consequences for the individual patient, such mistakes may 
lead to biased assessment of prosthetic failures overall. 
 
Being a relatively young field of research, many unresolved questions exist 
regarding the pathogenesis and colonization strategy of the bacteria involved. 
Werner Zimmerli has pointed out that spontaneously healing of a implant-related 
infection has never happened (Zimmerli, 2014) – so “knowing the enemy” must be 
one of the next steps for finding the possible weak spots for a counter-offensive. 
Experience from the clinical setting and laboratory experiments need to be 
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supplemented with in vivo experiments in order to get more insight into 
phenotypes and to disentangle the complexity. A crucial point is to analyse effects 
of alternative antibiofilm compounds on a molecular level, hopefully identifying 
backdoors for eliminating implant-related infections without a surgical intervention 
in the future. 
1.4. PRIS – a clinical study 
“Prosthesis: Reduction of Infection and Pain” (Danish acronym PRIS) was a project 
running from 2010-2014 with participation of Aalborg University Hospital, Aalborg 
University, and the Danish Technological Institute together with several private 
companies. The project was funded by The Danish Council for Technology and 
Innovation (no. 09-052174). The goals set for the project were to develop new 
molecular and medico techniques, serological markers, and diagnostic imaging 
techniques for diagnosis in patients experiencing failure of their hip or knee 
prosthesis without an immediate cause, i.e. either infection or aseptic failure. The 
main benefit of the interdisciplinary collaboration should be faster diagnosis and 
treatment, and avoidance of unnecessary surgical interventions.  The PRIS project 
provided the framework for the extensive microbial diagnostics in Larsen at al. 
(Larsen et al., Draft)Paper 3.  

Chapter 2 Detection and identification of bacteria in PJI 
Chapter 2. Detection and identification of 
bacteria in PJI  
In addition to the findings mentioned in section 1.2, the diagnosis of a PJI is based 
upon the intraoperative specimens that are instrumental for demonstrating the 
causative microorganisms and thereby also provides a basis for targeted treatment 
of infection.  
Any diagnostic method must be proven fit for the purpose in accordance with 
multiple criteria, of which accuracy, robustness and expedience are among the 
most important (Guyatt et al., 2012; Peeling et al., 2010). Expedient and reliable 
detection and identification of infecting microorganisms translate into early 
directed antibiotic therapy. Likewise, timely negative reports have a significant 
impact on patient management. 
2.1. Sampling logistics 
"In every chain of reasoning, the evidence of the last conclusion can be 
no greater than that of the weakest link of the chain, whatever may be 
the strength of the rest."  
Thomas Reid: “Essays on the Intellectual Powers of Man” 1786 
 
In every organization with multiple functions and different locations, logistics 
becomes a critical issue. The study by Larsen et al. (Larsen et al., 2014a)Paper 2 was 
influenced by several autonomous factors: It was part of a larger clinical diagnostic 
study (PRIS) involving several clinical specialities, and patient participation was 
voluntary for every part of the study. The cooperation was a thorough learning 
process both for clinical and non-clinical partners, who had to accommodate 
different aims and practices. This logistic challenge must be kept in mind when 
considering the design of the study and the inclusion criteria for patients.  
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2.1.1. Practices of clinical microbiology 
In general, staff members of clinical microbiology departments are not directly 
involved in sampling procedures for diagnostic specimens. In acute care areas, 
operation theatres and wards, these tasks are taken care of by physicians, nurses, 
and biotechnicians presumably following specific guidelines. 
For a study across different hospitals and with participation of many healthcare 
workers, a special effort is needed to secure standardised and complete specimen 
sets. Variation in sampling for standard microbiology has been shown to be critical 
for sensitivity and specificity of PJI diagnosis (Atkins et al., 1998). Especially for 
comparisons of specimen types and diagnostic techniques, the individual surgeons’ 
personal skills and preferences would weaken the foundation of the study. 
Thus, the primary challenge in our study (Larsen et al., Draft)Paper 3 was to fulfil an 
ambitious goal to define an optimal specimen set for the diagnosis of PJI. Many 
publications have compared two different specimen types against each other 
(Table 4), but we would like to compare the utility of more than two specimen 
types and several methods based on the specimens collected simultaneously 
during the operation. For this purpose a simple strategy was developed (Larsen et 
al., 2014a)Paper 3 which made uniform sampling possible across different hospitals 
and hospital staff. A pre-packed sample box was made, which covered the entire 
range of specimens taken during surgery and with sample tubes containing 
appropriate transport medium for every specimen type. The surgeons were 
informed about the rationale for the multiple specimens, and the colour-coded 
vials made it relatively simple for a nurse to handle them correctly. 
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Figure 2: (A) Sample boxes for joint puncture and (B) revision surgery. (A) Joint fluid is 
inoculated directly into a blood culture flask (BacT/Alert, bioMérieux, Marcy l’Etoil, France) 
and submitted for further culture examination and molecular diagnostics. (B) Sample tubes 
are colour coded in the revision surgery box in order to assist the operation staff in 
achieving complete sample sets. Sample tubes had a broad neck in order to facilitate the 
deposition of the tissue sample (Larsen et al., 2014a)Paper 3. 
 
Despite its complexity the standardised sampling resulted in a completeness in the 
order of 90% (updated from Larsen et al. 2014a)Paper 3.  The use of this concept 
might also be applicable in other areas of surgery and medicine where systematic 
sampling is important, especially if variation (random or non-random) may impact 
negatively on the downstream results.  
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2.1.2. Transport media 
Ideally a diagnostic specimen should be processed immediately after sampling, but 
there are numerous barriers to such a level of service even in a research setting, 
and it would also hamper the translation of the results into clinical practice 
especially if highly skilled personal is required out of hours. Therefore, the next 
best option is to secure transport of specimens to the laboratory in their original 
condition as soon as possible by existing transport services. For the purpose of 
culturing, microorganisms have to be kept alive outside of the human body and 
with the composition of microbial communities being as intact as possible. 
Therefore, the choice of transport media requires knowledge of the likely 
microorganisms and downstream analysis together with practical considerations in 
the clinical situation. 
For culture-based diagnosis of PJI, the transport media have to preserve a broad 
range of skin commensals including anaerobes and fastidious bacteria. Three 
widely used transport media are available on the marked, Amies (Amies, 1967), a 
variation thereof, and Stuart medium (Stuart, 1946). These media have been 
evaluated according to the M40-A protocol (Clinical and Laboratory Standard 
Institute, USA) by Tano and Melhus (Tano & Melhus, 2011). After 24 hours of 
simulated transport at room temperature all media were able to maintain bacterial 
viability, but the Stuart medium had the lowest ability to maintain the number of 
colony forming units (CFU) per mL whereas Amies medium promoted growth that 
might be a problem when tested with a polymicrobial inoculum. A drawback with 
the study of Tano and Melhus is the limited selection of bacteria tested. In recent 
years the focus has mainly been on the evaluation of swab transport systems in 
relation to the physical properties of the swab while the media have been 
variations of those mentioned above (Stoner et al., 2008). 
The choice of transport media for molecular testing is strongly dependent on the 
downstream analysis. As an example, in the PRIS study the extraction of nucleic 
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acid for 16S rRNA sequencing analysis was done by use of MolYsis complete 5 kit 
(Molzym, Germany), which removes human DNA and extracellular DNA before the 
extraction of the bacterial DNA from intact cells. Therefore it was of great 
importance to secure that bacteria in the specimens were preserved intact during 
long-term storage, which was fulfilled by a transport medium with a final 
concentration of >10% glycerol (Larsen et al., 2014a)Paper 3. 
2.2. Diagnostic methods for PJI in clinical microbiology 
At the time of conception of the PRIS protocol there was no international gold 
standard for the diagnosis of PJI. Nevertheless, culturing tissue biopsies obtained 
from the vicinity of the prosthesis was given high diagnostic weight. The recently 
published guidelines from ESCMID and IDSA (see page 19) both conclude that there 
is no unambiguous definition of PJI, but both recommend the use of multiple 
intraoperative tissue biopsies for the microbial diagnosis and processing of 
components of the prosthesis is mentioned only as a possibility (Høiby et al., 2015; 
Osmon et al., 2013). 
2.2.1. Diagnostic samples for microbiology 
Since the mid 1990's orthopaedic surgeons in North Denmark Region have used 5 
soft tissue biopsies obtained according to Kamme & Lindberg for diagnosis  of PJI. 
The biopsies are sampled from one location in proximity of the prosthesis with 
separate surgical instruments, sent in separate containers, and processed 
individually (Kamme & Lindberg, 1981; Mikkelsen et al., 2006). In the original 
study, Kamme & Lindberg obtained specimens both during primary total hip 
arthroplasties in patients without signs of infection and during revision surgery in 
patients with infectious and non-infectious loosening of the prosthesis. A cut-off of 
≥3 biopsies with concordant culture findings made the best distinction between 
bacteria of clinical significance and contaminants. 
The systematic use of multiple specimens from the area possibly infected reduces 
the risk of a false positive diagnosis of infection as many infections are caused by 
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normal skin commensals that may contaminate the surgical field or culture media 
in the laboratory, such as P. acnes and Staphylococcus epidermidis (Osmon et al., 
2013). During the last 20 years the importance of multiple specimens have been 
corroborated (Atkins et al., 1998; DeHaan et al., 2013; Hall-Stoodley et al., 2012). 
Recently, Bémer and co-workers confirmed the need for multiple specimens and in 
addition they introduced an optimal number of four independent of the specimen 
types, thereby acknowledging the legitimacy of reducing resources needed for 
diagnosis of PJI as much as possible (Bémer et al., 2015).  
Culturing is often used as the gold standard for diagnosis of bacterial infections. It 
is a relatively simple method and only standard equipment is necessary, but skilled 
laboratory technicians are required for correct handling. The detection level can be 
very low in terms of CFU and is relatively robust to variation in the ratio between 
bacteria and human tissue cells. Conversely, prolonged incubation and multiple 
inspections of bacteriological media are time consuming, and despite of all efforts 
some viable bacteria may not be able to grow, and previous antibiotic treatment 
may lead to spuriously negative culture results. The principles of culture methods 
in clinical microbiology were originally invented in the laboratory of Robert Koch 
and were aimed to suit planktonic bacteria (Löffler, 2001). Reduced effectiveness 
for bacteria growing in biofilms has been demonstrated (Hall-Stoodley et al., 2012). 
The main explanations given for culture-negative PJI are inaccurate sampling, 
antibiotic treatment before sampling, infection caused by fastidious or 
unculturable bacteria, insufficient incubation time, and biofilm mode of growth 
(Hall-Stoodley et al., 2012; Parvizi & Harwin, 2014; Zimmerli et al., 2004). 
Therefore, alternative methods and specimen types have been investigated in a 
number of studies comparing sensitivity and specificity (Table 4). 
In an early phase of the PRIS study, Xu and co-workers (Xu et al., 2012) showed 
that molecular techniques could reveal microorganisms in addition to those 
detected by standard culture methods. Several explanations for the discrepancies 
were considered: a too brief incubation period for culturable bacteria, delayed 
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switch from ‘biofilm mode of growth’, or unsuited culture media. Still, some of the 
bacterial species found only by molecular methods should be straightforward to 
culture, and one significant drawback of the study was that the specimen types 
analysed were not carefully matched. A heterogeneous distribution of biofilm 
infections has been demonstrated, and it is likely that the specimens analysed did 
not have the same bacterial composition (Hall-Stoodley et al., 2012; Thomsen et 
al., 2010). The PRIS project made it possible to design a prospective study in a way 
making possible direct comparisons between different specimen types and 
between culture-based methods and 16S rRNA sequencing (Larsen et al., Draft)Paper 
3. 
Box 1 Parameters to be considered for the evaluation of a diagnostic test (Peeling et al., 
2010). 
Evaluation of a diagnostic test  
Evaluation of a diagnostic test is dependent on the following parameters to give a proper 
picture of the actual performance for the intended purpose. 
 
• Test performance 
Sensitivity, specificity, positive and negative predictive value 
The test has to cover both symptomatic and asymptomatic patients. The 
specificity can be more or less important depending on low cost and side effect of 
the treatment.  
 
• Usability 
The usabillity of the diagnostic test should be evaluated in context of the clinical 
setting, it is attented for. Including parameters as time consumptions, human vs. 
machine, storage, and shelf lifetime. 
 
• Study group for evaluation 
The study group should resemble the population in which the test will be applied. 
The group should be clearly defined with inclusion and exclusion criteria and 
should have a proper size. 
 
• The reference standard should be clearly defined. 
 
 
2.2.1.1 Sonication of joint prosthesis components 
The increased attention to biofilm formation on foreign bodies has brought 
prosthesis components in the foreground for diagnostic testing (Høiby et al., 2015; 
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Osmon et al., 2013). Sonication and quantitative culture of sonication buffer have 
been applied to joint prostheses, spine implants, and pacemakers (Piper et al., 
2009; Rohacek et al., 2015; Sampedro et al., 2010; Trampuz et al., 2007; Tunney et 
al., 1998).  
 
The laboratory handling requires suitable sterile containers for transport, sterile 
buffered saline to submerge the component (different variations have been 
published (Larsen et al., 2012)Paper 1), vigorous vortexing, sonication (40 kHz) and a 
second turn of vortexing (Figure 3). Aliquots of the sonication buffer are 
subsequently cultured on a range of media in a quantitative manner. Alternatively, 
blood culture bottles have been used for incubation (Portillo et al., 2015). 
 
 
 
Figure 3 Sonication procedure used for knee and hip prostheses at the Department of 
Clinical Microbiology, Aalborg University Hospital in the PRIS project (Xu, 2014) 
 
Sonication of prosthesis components has been shown to increase the sensitivity of 
culture compared to tissue biopsies, probably due to 1) the mechanical 
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dislodgement of bacteria, and 2) the enlarged sampling area from the entire 
surface of the prosthesis component following by 3) the concentration of bacteria 
by centrifugation of sonication buffer (Table 4) (Portillo et al., 2013; Tunney et al., 
1998; Zimmerli et al., 2004). Sonication (Figure 3) may accelerate growth resulting 
in faster positive culture reports compared with other specimen types from the 
same infection (Gomez & Patel, 2011). The explanation may be disruption of the 
cell wall/membrane, which initiates the transcription system for repair and thereby 
restarts persister cells in the biofilm and accelerates the growth rate of bacteria in 
the biofilm (Pitt & Ross, 2003). 
Sonication has underwent some modifications over time, most significantly by 
addition of vortexing before and after sonication (Portillo et al., 2013). Monsen and 
co-workers (Monsen et al., 2009) showed a sonication period of 5 minutes to be a 
compromise covering both Gram positive and Gram negative bacteria, but the 
technique could be even more sensitive for the culture of Gram positive bacteria 
by increasing the sonication time (e.g. S. aureus may tolerate up to 20 min of 
sonication). 
As mentioned before, the sonication buffer from prosthetic components is not only 
suited for culture by use of solid and liquid media, but also for inoculation of blood 
culture bottles similar to cultures of joint fluid (Font-Vizcarra et al., 2010; Hughes 
et al., 2001; Peel et al., 2016). Inoculation of sonication fluid into blood culture 
bottles has been shown to be more sensitive than culture using standard media (as 
well as culture of tissue biopsies) with a gain especially of fastidious bacteria and 
bacteria exposed to antibiotics (Levine & Evans, 2001; Portillo et al., 2015). 
Sonication buffer has also been found applicable for molecular diagnostics ranging 
from PCR-based methods including multiplex PCR to broad range 16S rRNA next 
generation sequencing (NGS) with notably high sensitivities (70 to 95%) and 
specificity (of 98-100%), which is generally a better performance than seen for 
culture-based studies using tissue biopsies and sonication of prosthesis 
Chapter 2 Detection and identification of bacteria in PJI 
37 
components (Achermann et al., 2010; Cazanave et al., 2013; Gomez et al., 2012; 
Tunney et al., 1999). 
 
2.2.1.2 Prolonged culture incubation time 
The choice of incubation time is a compromise between different concerns: 
Extended incubation increases the chance of growth of slow-growing or 
recuberating microorganisms, but may also increase the risk of contamination. For 
laboratory managers additional concerns include capacity of aerobic and anaerobic 
incubation facilities and workload due to multiple inspections, but a more 
important concern is the delay of a final diagnosis and treatment plan for the 
patient. As long as infection is not ruled out, the patient may be hospitalised for 
intravenous antibiotic treatment. Nevertheless, the attention to biofilm bacteria 
has led to gradual extension of standard incubation time (Hall-Stoodley et al., 
2012; Larsen et al., 2012)Paper 1. Butler-Wu and co-workers showed an app. 30% 
increase in cultures positive for P. acnes when the incubation period for specimens 
from shoulder prosthesis infections was extended to 14 days instead of 7 days 
(standard); this observation is within range of other studies (Schäfer et al., 2008; 
Skovby et al., 2011). Not only anaerobic bacteria may need prolonged incubation 
time: In one patient in our own study (Larsen et al., Draft)Paper 3 S. epidermidis was 
obtained by culture on day 10 from the sonication fluid from the prosthetic 
component and first on day 14 from tissue biopsies. The cultures were clearly in a 
biofilm mode of growth as shown by several types of colony morphology, which 
may explain why the patient had vague symptoms from a knee arthroplasty for 
more than a decade (Larsen et al., 2013)Paper 2.  
 
2.2.1.3 Results from the PRIS study 
In the PRIS study (Larsen et al., Draft)Paper 3 five different specimen types were 
investigated, joint fluid, soft-tissue biopsies, prosthetic swab (in situ), the 
prosthetic component, and bone biopsies. All specimen types were cultured for a 
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period of 14 days and were investigated for the presence of bacteria by 16S rRNA 
broad range PCR followed by sequencing if positive. 
The optimal specimen set for culturing was found to be joint fluid, soft-tissue 
biopsies, and the sonication fluid from the prosthesis component. Of note, neither 
the prosthetic swab nor bone biopsies contributed to the diagnosis (Figure 4). We 
found no single specimen type to be positive in all PJI patients, conversely, the 
different specimen types contributed differentially to the diagnosis of PJI 
depending on the microorganism. The time to culture positivity depended both on 
the specimen type and the microorganism. For early and acute onset infections 
with e.g. S. aureus. Streptococcus spp. and Enterococcus faecalis cultures of all 
specimens might be positive on day 1 or the microscopy of the joint fluid might 
indicate the infecting microorganism. The benefit of a broad collection of specimen 
types was largest in cases with slow infection (e.g. S. epidermidis and P. acnes) as 
well as in atypical and chronic cases. Dividing patients based on time of onset (see 
page 19) could be a rational sampling strategy prioritizing resources for patients in 
the grey area. The prolonged incubation period only added three extra patients 
(3/42, 7%) because of the contribution from different specimen types (Figure 5) 
 
The comparison between culturing and 16S rRNA sequencing showed that the 
latter only added a few extra findings to the culture reports. This method can 
therefore be restricted to cases where this contribution is essential, e.g. chronic 
cases especially with a protracted history and cases who have been exposed to 
antibiotics before sampling.  
In general, contributions from 16S rRNA sequencing have been restricted to liquid 
specimens which might be due to a much higher ratio between human and 
bacterial DNA in the final DNA extract from tissue biopsies compared to joint fluid 
and sonication fluid obtained with prosthetic components (Bémer et al., 2014; Ryu 
et al., 2014).  
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In the near future the focus must remain be on the difficult PJI cases where 
diagnosis remains a challenge.  
 
 
Figure 4 Contribution to positive results in cases where all specimens are present. (A) 35 
cases with complete sets of soft tissue biopsies, prosthetic component, and joint fluid. (B) In 
28 cases all specimen types were collected; neither bone biopsies nor prosthetic swabs 
contributed additional information (Larsen et al., Draft)Paper 3. 
 
2.2.2. PCR based diagnostics for PJI 
Molecular techniques for the diagnosis of PJI have not yet become standard in 
most laboratories (Bémer et al., 2014) despite the fact that PCR tests have been 
applied since the late 1990s (Tunney et al., 1999) ( Table 4). The reported 
sensitivities show a wide variation (range 16-100%) depending on specimen type 
and the PCR technique used. Additional factors that may be conducive to the 
variation are selection of patients, experimental design, comparability of 
specimens, and the assays’ technical parameters. Taking these limitations in 
consideration, molecular methods are still likely to be valuable supplements to 
conventional clinical microbiological diagnostic. 
Generally, two different strategies have been applied in clinical microbiology (Table 
4). The most frequent is based on multiplex qPCRs targeting common causative 
microorganisms by a combination of broad range 16S rRNA gene assays and 
species specific assays for S. aureus, CoNS, Streptococcus spp., anaerobic bacteria 
such as P. acnes, and 18S rRNA gene for fungi. The alternative strategy is based on 
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broad range 16S rRNA gene PCR screening followed by sequencing of the positive 
specimens.   
A 
 
B 
 
Figure 5: Distribution of positive specimens in relation to the day of culture positivity. (A) All 
positive specimens for all culture positive cases. (B) 8 culture positive cases who were not 
positive by our gold standard of periprosthetic tissue biopsies at day 6 (Larsen et al., 
Draft)Paper 3. 
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2.2.2.1 Multiplex PCR 
Multiplex PCR has been used successfully for PJI in several studies and especially 
for patients receiving antibiotic treatments prior to surgery (Achermann et al., 
2010; Cazanave et al., 2013; Portillo et al., 2012; Ryu et al., 2014). In particular, 
Cazanave et al. found it advantageous to combine broad range primers and specific 
sets of primer pairs for the most common PJI bacteria.  
The choice of species to be targeted by multiplex PCR assays is dependent on 
knowledge of the spectrum of bacteria previously linked to PJI, and rare bacteria 
will not be detected by this diagnostic approach. However, the method is 
expedient and has the potential for providing same-day diagnosis. In this sense 
multiplex PCR diagnostics is superior to bacteriological culture. 
 
2.2.2.2 Broad-range 16S rRNA PCR followed by sequencing 
Historically, broad-range 16S rRNA gene PCR has been popular for detection of 
bacteria since the original work of Tunney et al. (Tunney et al., 1999). Detection of 
the 16S rRNA gene is a distinct marker of bacterial presence, and subsequent 
sequencing allows phylogenetic classification of bacteria based on the 
heterogeneous regions (Harris & Hartley, 2003). Previously, the step after 
amplification has either been cloning of 16S rRNA followed by Sanger sequencing 
(Dempsey et al., 2007; Fenollar et al., 2006; Vandercam et al., 2008) or direct 
Sanger sequencing with and without RipSeq analysis if more that two bacterial 
species was present (Fenollar et al., 2006; Gomez et al., 2012). 
The use of more advanced sequencing methods will be descripted later. 
 
2.2.2.3 Drawbacks of PCR based diagnostics 
In the literature it is often emphasised that the primary benefit of using PCR-based 
diagnostics is a faster diagnosis of the infecting microorganism(s) compared to 
culture methods (Hall-Stoodley et al., 2012) . However, there are other important 
aspects of molecular methods that need to be studied. 
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Ryu et al. has briefly mentioned the ratio of human DNA to bacterial DNA being a 
problem when working with tissue specimens (Ryu et al., 2014). In specimens with 
few bacteria the amount of bacterial DNA can be very low in the final DNA extract 
either due to insufficient DNA extraction or ‘drowning’ in the overload of human 
DNA leading to false negative results. Using different DNA extraction kits we found 
both the detection limit and the background contamination profile (se next 
section) to vary, too. Specifically, we compared the performance of MolYsis 
complete kit 5 (Molzym, Germany) with the Dneasy Blood & Tissue kit (Qiagen, 
USA) for DNA extraction of complex human specimens, and with the first kit we 
obtained PCR bands of correct size after broad range PCR while there were many 
unspecific bands from the extractions with the latter one (Xu et al., 2016a). 
 
 
 Figure 6. Agarose gel electrophoresis of the products from a broad range 16S rRNA gene 
PCR amplified using 26F and 518R primers and 30 cycles. DNA was extracted from pure 
cultures of Enterococcus phoeniculicola and complex human specimens.  With two different 
DNA extraction kits; Dneasy Blood & Tissue kit (Qiagen, USA) and MolYsis complete kit 5 
(Molzym, Germany). Strong smears from spiked culture extracted with Dneasy Blood & 
Tissue kit indicate clear influence of human DNA on PCR (Xu et al., 2016a) 
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Table 5 Advantages and disadvantages of the culture-independent methods covered in this 
thesis (modified after Rudkjøbing, 2012). 
 Advantages Disadvantages 
FISH Fast (< 1 day) 
Cost efficient 
Probes can be designed for each taxonomic level 
Less sensitive to contamination than PCR-based 
methods 
Provide information about cell morphology, 
number, spatial distribution or the cellular 
environment 
 
Insufficient probe penetration and 
hybridization may result in low signal intensity 
Low physiological state may result in low rRNA 
content and hence low signal intensity. 
High detection limit. Often difficult to detect 
low numbers of bacteria. Less sensitive than 
amplification based methods 
Potential autofluorescence of biomaterial or 
host tissues 
QPCR Fast (< 1 day) 
No post-amplification handling 
High sensitivity 
Can provide quantitative results 
Many available assays 
Can be multiplexed 
Only targeted species will be detected 
Sensitive to contamination 
Sensitive to PCR inhibitors 
 
PCR/ESI-TOF-
MS 
(Ibis)  
Fast (< 1 day) 
Can potentially identify all species by 
combination of broad and narrow range primers 
Can provide quantitative information 
Automated  
Not widely tested 
Costly 
Data analysis is a black box 
Broad-range 16SrRNA PCR based methods 
Direct Sanger 
sequencing 
(followed by 
RipSeq) 
Fast (< 1 day) 
High sensitivity 
Long read length 
Can provide species information by BLAST 
sequences in databases 
Generally requires single target sequence in 
one sequencing reaction. In the case of 
polymicrobial infection, RipSeq can be used to 
resolve mixed chromatogram (up to 3 species) 
Costly 
Cloning and 
Sanger 
sequencing 
Can separate individual PCR fragments 
Near full-length 16S rRNA gene sequence can be 
obtained  
Can provide species information by BLAST 
sequences in databases 
 
Costly  
Time consuming and labour intensive (> 3 days) 
An adequate number of clones need to be 
sequenced to avoid missing low abundant 
species  
Next 
generation 
sequencing 
High throughput 
High species resolution 
Can provide species information by searching 
databases 
Continuous fast improvement of the 
technologies 
 
Time consuming (>2 days) 
Require extensive bioinformatics analysis 
High cost per run  
Read length is limited to around 500 bp 
currently 
 
2.2.2.4  A bioinformatics approach for removal of contamination and estimation 
of cut-off, an example 
16S rRNA amplicon sequencing is used to identify and compare bacteria present in 
the specimen. The microbial diversity can be compared between different 
specimens independent of culturing and nonculterable bacteria can be 
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investigated. The 16S rRNA genes are amplified by PCR using broad-range primers 
(v1-v3 region, 30 cycles) including barcodes to identify the specific specimen and 
sequencing can be applied. During extraction of DNA the specimen can be exposed 
to contamination both from the DNA extraction kit itself and from the laboratory 
environment even though all precaution have been taken. In NGS, the background  
contamination profile has been shown to have its individual bacterial fingerprint 
for every laboratory and every molecular kit combination in play, especially for 
specimens with a very low amount of target bacteria (Salter et al., 2014; Xu et al., 
2016a). The above problems are not relevant for specimens containing high 
amounts of bacteria because the target will outcompete less abundant 
contaminants in the specimens in the initial PCR preparation. However, for the 
specimens with low amounts of bacterial DNA, the contamination can become 
significant in the dataset, and a trained bioinformatician is needed to safeguard the 
interpretation of the results.  
For the correct classification of true amplification-positive and amplification-
negative specimens in the PRIS study the contamination profile was ascertained in 
order to distinguish the amount of background reads from the true positive 
specimens (Larsen et al., Draft)Paper 3.  
For this purpose we analysed a subset of specimens investigated by molecular 
methods in the PRIS dataset (32 patient specimens of all specimens types, 16 
negative DNA extraction controls, one negative PCR control, and one positive DNA 
extraction control). For every specimen, the number of reads sequenced was 
normalised to the amount of DNA (in nanograms) pooled for sequencing, and net 
the numbers were plotted against the DNA input. Figure 7 shows the results from a 
data analysis using 97% similarity for classification of OTU (data from all sequences 
top left and specimens with less than 500 reads/ng DNA input top right). There was 
an overlap between the amount of reads from the negative controls and some of 
the specimens. After removing the OTUs with less than 100 or 200 reads a clear 
separation was seen between the true positive (above 200 reads/ng DNA) 
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specimens and negative controls together with negative specimens, and it is 
possible to set a cut-off of 200 reads/ng DNA input for these runs, to distinguish 
the amplification-positive specimens and the amplification-negative specimens. For 
the specimens just above 200 reads/ng DNA input and less than 500 reads there is 
a grey area and individual estimation has to be made, taking into account other 
specimens from the same patient, the microorganism in question, and the results 
obtained by culture as well as clinical evaluations. Similar results were achieved for 
99% similarity of OTU (not shown). 
The above estimation can be applied to all specimens in the dataset regardless of 
the sequencing results, but looking specific at the contamination fingerprint in the 
negative controls and thereby at the OUT collection which have to be removed 
from the final data, the contamination profile shows typical environmental bacteria 
evenly distributed across the negative controls and the specimens (with low 
amount of reads). Also more common bacteria such as Staphylococcus sp. and 
Propionibacterium sp. (possible P. acnes) are represented with reads in every 
negative control. This gives an indication that a specific cut-off has to be set for 
these two bacteria. 
Specimens positive for Staphylococcus sp. are often easy to recognise. The 
numbers of reads tend to be above 1000 reads/ng DNA input (Figure 8, top left) 
and this is characteristic for true positive specimens with all types of bacteria. For 
the specimens below 150 reads/ng DNA input, the cut-off was 80 reads/ng DNA 
input independent of the removal of OTUs with less than 100 or 200 reads for 
Staphylococcus sp. OTU. The grey area between 80-150 reads/ng DNA input needs 
an individual estimation in relation to the overall diagnostic results. 
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Figure 7. Estimating the cut-off for all sequences. Reads are normalised against ng DNA input 
of the PCR product into the multiplex for sequencing and plotted against the amount of ng 
DNA input. Open: specimens, closed: negative controls. Top left: total reads, all specimens. 
Top right: total reads, section of reads below 500 reads/ng DNA. Bottom left: OTUs less than 
100 reads removed. Bottom right: OTUs less than 200 reads removed. 
 
 
Figure 8. Estimating cut-off for Staphylococcus sp. Reads achieved from sequencing are 
normalised against ng DNA input of the PCR product into the multiplex for sequencing, and 
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plotted against the amount of ng DNA input. Open: specimens, closed: negative controls. 
Top left: total reads, all specimens. Top right: total reads, section of reads below 150 
reads/ng DNA. Bottom left: OTUs less than 100 reads removed. Bottom right: OTUs less than 
200 reads removed 
 
 
Figure 9. Estimating cut-off for Propionibacterium sp. Reads achieved from sequencing are 
normalised against ng DNA input of the PCR product into the multiplex for sequencing, 
plotted against the amount of ng DNA input. Open: specimens, closed: negative controls. 
Top left: total reads, all specimens. Top right: total reads, section of reads below 100 
reads/ng DNA. Bottom left: OTUs less than 100 reads removed. Bottom right: OTUs less than 
200 reads removed 
 
For the Propionibacterium sp. (Figure 9), two specimens in the data set were 
convincingly positive (top left; only one within the plotted area). The rest of the 
specimens had 100 reads/ng DNA input or below. They were plotted as above, and 
when all Propionibacterium sp. OTUs with less than 200 reads were removed, it 
was possible to see a separation between the true negative specimens and 
specimens in the grey area. A cut-off of 60 reads/ng DNA input was now feasible 
with a grey area between 60-100 reads/ng DNA input where specimens need 
further evaluation. 
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This kind of evaluation has to be made for every sequence dataset, especially in the 
light of the results mentioned above by Salter et al. (2014). Optimally, the 
contamination profile should be evaluated every run and more pragmatically, at 
least every time changes are made in the preparation of specimens for sequencing.  
 
2.3. Explorative approaches  
Investigations of non-culture based methods for the diagnostic of PJIs have been 
on-going for the last 20 years. In the pursuit of an easy and less invasive diagnostic 
method, different biomarkers such as C-reactive protein (CRP), joint fluid leukocyte 
count and the more explorative α-defensin 1-3 have been investigated. However, 
this thesis will not address the biomarkers, but focus on the diagnostic 
microbiology in PJI in hips and knees (Cipriano et al., 2012; Deirmengian et al., 
2014; Parvizi et al., 2011a, b).  
 
2.3.1. PCR/ESI-TOF-MS 
PCR/ESI-TOF-MS also called IRIDICA (Abbott) combines PCR with high-performance 
electrospray ionization time-of-flight mass spectrometry (ESI-TOF-MS). Using Bac 
spectrum kit, unknown DNA is amplified with several primers covering both broad 
range and also more species-specific sequences including Candida spp. and 
selected antibiotic resistance genes (e.g. mecA and vanA) (Ecker et al., 2008).  
After PCR, the PCR products are automatically desalted. Then the ESI denaturates 
each product, which is subsequently weighed by TOF-MS with a precision enough 
to calculate the compositions of nucleotides. Based on a triangulating algorithm 
bacterial species are identified as a result of the calculated base compositions of 
the multiple PCR products and a database search. By comparing MS peaks in 
relation to internal standards, it is possible also to quantify bacteria in the 
specimens (Ecker et al., 2008). 
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Table 6 Overview of the applied methods and results for a PJI case study (Xu et al., 2013) . 
The numbers in the brackets refer to the number of analysed clones belonging to the 
species. 
Procedure Method Specimen Organism Comments 
Debridement with 
prosthesis retention 
(housecleaning) 
Culture 5 Tissue biopsies - Culture was 
negative most 
probably due to the 
ongoing antibiotic 
therapy. 
Cloning Joint fluid S. dysgalactiae subsp. 
equisimilis (72) 
A total of 72 clones 
were sequenced 
and analyzed. All of 
them identified the 
same species. 
Prosthesis swab S. dysgalactiae subsp. 
equisimilis (69); 
Propionibacterium 
granulosum (7); Kocuria 
palustris (5); Paracoccus 
sp.(3); P. acnes (3); 
Anaerococcus sp. (2); 
Achromobacter 
xylosoxidans(1); 
Peptoniphilus sp. (1);  
Uncultured bacterium (2) 
A total of 83 clones 
were sequenced 
and analyzed. 
Ibis Tissue biopsy Streptococcus pyogenes  
Bone biopsy S. pyogenes  
Pyrosequencing Tissue biopsy S. dysgalactiae  
 Bone biopsy S. dysgalactiae  
 
The system is predicted to fulfil the requirements for molecular diagnostic in 
clinical microbiology. Xu et al 2013 (Table 6) applied the research system Ibis 
Biosciences T5000 biosensor (now IRIDICA, Abbott) on a PJI (hip prosthesis) and 
made a comparison with culture, cloning, and pyrosequencing. Cultures from 
peroperative tissue biopsies were negative probably because of on-going antibiotic 
therapy at the time of surgery. Cloning from the prosthetic component was 
polymicrobial with the main products derived from Streptococcus dysgalactiae. The 
majority of the pyrosequencing reads were also S. dysgalactiae. The Ibis identified 
Streptococcus pyogenes, as the most likely species in tissue and bone biopsies, 
which indeed was close taxonomically to the causative agent S. dysgalactiae. 
In the newer versions of the Ibis the specificity remains a challenge, and the 
method is still prone to contamination during handling which requires a cautious 
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interpretation of the results (Brinkman et al., 2013; Greenwood-Quaintance et al., 
2014; Jacovides et al., 2012). 
 
2.3.2. Fluorescence in situ hybridization 
Fluorescence in situ hybridization (FISH) is a powerful tool to investigate biofilm. It 
is well suited for the study of the architecture of biofilm formed in the human body 
in contact with tissues as well as humoral and cellular immune mediators (Hall-
Stoodley et al., 2012; Moter & Göbel, 2000). The method was not a part of the 
clinical routine but was applied as an explorative method in the PRIS project. With 
the FISH method we are able to detect specific nucleotide sequences by 
fluorescence labelled probes. An often used target site is ribosomal RNA primarily 
because of the high numbers of ribosomes in bacteria, but also because of the 
possibility of targeting more or less conserved regions (Woese, 1987)  
FISH is less sensitive to contamination compared with PCR based techniques and 
has therefore been used for demonstration of biofilm directly on implants such as 
prostheses or central venous catheters (Stoodley et al., 2011; Thomsen et al., 
2011). The limited area of a medical implant, which can be investigated by 
microscopy, calls for preparatory techniques such as scraping the surface or 
sonication combined with centrifugation.  
Peptide Nucleic Acid-probes (PNA-probes) are mostly used for direct identification 
of bacteria growing in blood culture bottles for accelerating the time for diagnosis 
(Deck et al., 2012). Diagnostic kits are available (AdvanDx, USA), but the 
commercially available probes are still limited. The FISH method demonstrates the 
aggregation of cells (Figure 10), and in an optimal combination with confocal 
microscopy the biofilm composition and distribution can be visualised (Thomsen et 
al., 2011). To overcome heterogeneous distribution of bacteria on the surface of 
infected prostheses, we used a modified PNA-FISH protocol. With this protocol we 
have been able to lower the detection limit to ≥102 CFU/mL via concentration of 
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the sonicate specimen on a polycarbonate filter, (Figure 10 bottom) (Larsen et al., 
2014b). 
 
 
Figure 10. Demonstration of single cells and microcolonies by use of different PNA-FISH 
probes. (Top): Enterococcus faecalis PNA-FISH probe (red) and universal bacterial PNA-FISH 
probe (green). (Bottom both pictures): Staphylococcus aureus PNA-FISH probe (green) and 
universal bacterial PNA-FISH probe (red). S. aureus should appear yellow when both probes 
hybridised. However, only few cells are yellow which can be caused of poor hybridization or 
shift in focus layer during documentations. No red cells indicate that it is a S. aureus 
monoinfection (Larsen et al., 2014b). 
 
2.4. Knowing the ‘enemy’ 
The literature summarised in Table 4 indicates that culture methods in 
combination with molecular methods and a range of specimen types can provide a 
more comprehensive picture of microorganisms involved in PJI. This augments the 
understanding of the pathogenesis of biofilm infections.  In an allied field of 
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microbiology, mapping metabolic pathways in the genome of unculturable 
anaerobic bacteria has led to development of media overcoming restrictions of 
growth (Sommer, 2015). Other studies have suggested that the presence of some 
bacteria does not necessarily implicate an infection that requires treatment 
(Burmølle et al., 2010; Røder et al., 2015). Others believe that some 
microorganisms might act synergistically in polymicrobial infections, and the 
bacterial diversity itself may promote a chronic infection in addition to the 
pathogenicity of the individual bacteria (Brogden et al., 2005; Burmølle et al., 2014; 
Ehrlich et al., 2005). Since the contribution of individual bacteria in the 
pathogenesis of polymicrobial infection has not yet been explored extensively, 
different “omics” strategies might help to show the hidden life of the enemy and 
possibly direct new treatment strategies for biofilm-related infections.  
 
2.4.1. Towards the optimal diagnostic strategy 
All diagnostic methods have advantages and limitations. Few molecular techniques 
are used regularly or even routinely for the diagnostic of PJI, and thus most 
diagnoses are still based on culture. The conventional techniques in clinical 
microbiology are based on isolation of the most prevalent planktonic and fast 
growing pathogens on/in agar or fluid media, which might miss more fastidious 
and/or slow growing bacteria together with more uncommon non-culturable 
bacteria. For the diagnosis of PJI, future diagnostics have to overcome these 
limitations. 
The optimal diagnostic tool should be expedient, equally applicable to common 
specimen types, both sensitive and specific, and robust to variations in the clinical 
setting as well as in the diagnostic laboratory. It should provide the species of the 
infecting organism(s), phenotypic form (biofilm/planktonic), pathogenic factors 
expressed, and potential resistance mechanisms, thus providing the best treatment 
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options. NGS and PCR/ESI-TOF-MS might fulfil some of these requirements, at least 
in theory. 
 
NGS techniques have via whole genome sequencing (WGS) been used for the 
investigation of host-pathogen interactions and the epidemiology of outbreaks, but 
the use for routine clinical diagnostics is still in the making (Punina et al., 2015). 
Over the years the price of sequencing has been dropping (National Human 
Genome Research Institute, USA), and at present the bottleneck for using 
sequencing techniques is the analysis and interpretation of the large data output, 
together with the estimations of the clinical impact. 
In the foreseeable future, culture techniques will remain a mainstay for the 
diagnosis of PJI, as they are affordable and cover most of the causative agents. 
Molecular methods can be reserved for a selected group of patients in whom 
culturing has failed or is likely to fail. The most pertinent question is therefore 
which combinations of specimen types and techniques are most effective (being 
daring enough to refer to this as the optimal combination). 
In our study (Larsen et al., Draft)Paper 3 the optimal specimen set for culturing was a 
combination of joint fluid, soft tissue biopsies and the sonication fluid from the 
prosthesis component. Others studies (Bémer et al., 2014, 2015; Butler-Wu et al., 
2011; Font-Vizcarra et al., 2010; Gallo et al., 2008; Gomez et al., 2012; Hughes et 
al., 2001; Peel et al., 2016; Roux et al., 2011; Schäfer et al., 2008; Trampuz et al., 
2007) have investigated the use of individual specimen types against each other 
but no one has addressed the question of the optimal specimen set taking in 
account that no technique and/or specimen cover the entire spectrum of PJI 
infections. In our own study (PRIS) we investigated several parameters, and the 
sampling in parallel of different specimen types allowed direct comparison 
between specimen types and methods (foremost culture media, an extended 
incubation period. and 16S rRNA sequencing) Out of the 43 PJI cases in the study, 
12% (5/43) had culture-positive project specimens within the standard incubation 
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period of 6 days. Concurrently, cultures of standard soft tissue biopsies confirmed 
67% (29/43). Three additional cases had late culture-positive project specimens 
(i.e. after 7 to 14 days of incubation). Thus, in all 19% (8/43) had culture-positive 
project specimens; this figure is comparable to other studies (for further details, 
see summary of Paper 3 on page 62). (Butler-Wu et al., 2011; Schäfer et al., 2008). 
It is potentially an important observation that a broad collection of specimens may 
shorten time to positivity and hence favour shorter incubations times. The 
comparison between culturing and 16S rRNA sequencing showed that sequencing 
only added only a few extra findings to the culturing reports.  Compared to 
culturing, the molecular methods are relatively costly and time consuming and 
require many working hours of skilled laboratory personal. Therefore the use of 
this method is suggested to be restricted for cases in whom the results can be 
crucial, e.g. long-term chronic cases and cases exposed to antibiotics before 
sampling. 
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Chapter 3. Understanding microbial biofilms 
In chapter 2 the focus was on detection of bacteria present in biofilms, here the 
focus will be on revealing how they survive and grow in vivo. One of the key factors 
for survival in a biofilm infection is the ability to utilise proper carbon sources and 
electron acceptors from the environment within the human host and to maintain a 
proper environment for survival. Exploring the metabolism of bacteria in vivo may 
help to understand their ‘secret life’ and how to fight them. Several different 
approaches can help to elucidate parts of this question. By understanding the 
metabolic activity in addition to the virulence properties, new targets for bacterial 
eradication may become available, offering alternatives to antibiotics, which often 
fail biofilm infections (Rohmer et al., 2011). 
3.1. Investigations of biofilm infections 
A variety of investigation models contribute together with studies in patients to an 
increasing body of knowledge regarding implant-related infections within different 
areas. This multifaceted approach is needed to cover the complexities of biofilms in 
vivo. In vitro models are simple to set-up and suited for investigation of biofilms 
under standardised and systematically varying conditions, e.g. bacterial-
biomaterial-mammalian cell interactions step by step in short-term perspective, 
whereas the in vivo models allow the study of long-term interactions and biological 
integrations (Lebeaux et al., 2013; Roberts et al., 2015; Subbiahdoss et al., 2013). 
3.1.1. In vitro models 
The advantages of in vitro models are low-cost and simplicity of set-up with good 
possibilities for controlling single parameters within the system and maintaining a 
high throughput for screening purposes. A comprehensive comparison of different 
model systems for studying biofilm infection in vitro can be found in Roberts and 
co-workers (Roberts et al., 2015). The disadvantages of in vitro models are 
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primarily the simplicity of the systems that does not resemble the complexity of in 
vivo situations, e.g. they do rarely reflect oxygen and nutrient gradients found in a 
‘real’ biofilm infection (Roberts et al., 2015). Another notable example is the fact 
that typical mushroom-shaped biofilm forms are seen in flow cells but never 
observed in vivo (Figure 11).  
 
 
Figure 11 Confocal laser scanning micrographs of a 3-day old mushroom shaped biofilm 
formed by a Pseudomonas aeruginosa wild-type strain in a continuous flow cell system. The 
central image shows top-down view and the flanking images show vertical optical sections. 
The bar represents 20 µm (modified from Roberts et al. 2015, Bjarnholt, unpublished 
results) 
 
For improving in vitro models to mimic the in vivo systems even more, a two-
culture system offers the possibility of including both bacteria and mammalian 
cells. A relevant example is a model mimicking insertion of an implant with biofilm 
formation in the presence of mammalian cells (Subbiahdoss et al., 2009, 2011). The 
authors found that the formation of biofilm by low-virulent S. epidermidis was 
dependent on the ratio between bacteria and mammalian cells, whereas highly 
virulent bacteria such as S. aureus and P. aeruginosa producing exotoxins often 
won the ‘race for the surface’ and were less dependent on the ratio between 
bacteria and mammalian cells. 
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The choice of model depends on the questions to be answered. However, results 
obtained with in vitro models should be extrapolated cautiously to in vivo 
infections, and in the end results must be confirmed in vivo. As an example the 
RNA gene expression profile from in vitro culture of S. aureus shows very distant 
relations to in vivo gene expression profiles of a human PJI and the implant 
infection in a guinea pig model. Even though in vivo expression was studied in so 
different mammalian hosts like guinea pig and man, in vivo gene expressions 
profiles clustered together (Larsen et al., Draft)Paper 4. 
By use of in vivo animal models, the study of implant-related infections comes one 
step closer to human infections. The in vivo models are more complex systems with 
interplay between the host’s immune defence and multiple physicochemical 
factors such as nutrient availability, oxygen tension, and pH. The unique 
combination of all these factors cannot be mimicked by in vitro systems, even with 
multi-culture approaches (Subbiahdoss et al., 2013).  
However, the accessibility of in vivo models is restricted by national and 
international legal regulations and special animal facilities are required. 
Consequently, such studies are time-consuming and require long-term planning 
from the experimental design through legal approval until the experiments are 
conducted and results are ready for analysis. In this process, the choice of model is 
most important. For the right choice, the biology of the experimental animal has to 
be considered together with animal behaviour as this might heavily influence the 
final results. A comprehensive comparison of different model systems for studying 
biofilm infection in vivo can be found in Lebeaux and co-workers (Lebeaux et al., 
2013). In our study (Larsen et al., Draft)Paper 4 the question asked was “How does 
the implant-related S. aureus biofilm infection behave when exposed both to the 
host’s immune defence and moxifloxacin treatment?” To answer the question, an 
established S. aureus implant-related infection model was needed. Our choice was 
the tissue-cage model in guinea pigs (Zimmerli et al., 1982), where the host 
response to the implant has already been described (Zimmerli et al., 1984). This 
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facilitates interpretation of the results. It is well-known that differences in genetics 
and immune profiles between animal species give different results even with the 
same approach. Thus, establishing a long-term infection in a guinea pig model is 
more predictable compared to mouse and rat models in which spontaneous 
clearing of infection happens quite offend. The spontaneous clearance has not yet 
been observed in humans, and therefore the choice of the guinea pig model was 
deemed more relevant for the study of an implant-related infection (Zimmerli, 
2014).  
3.1.2. Investigating PJI in vivo 
The study of biofilms in vivo is not reserved to animals, but is also feasible in 
humans in certain situations. However, one must be aware of the large diversity in 
patient background variables: age, gender, co-morbidities, various treatments, the 
presumed duration of the biofilm infection, and different infecting microorganisms. 
Such unique studies provide an insight into the “real world”, but the 
generalizability remains questionable. Xu et al. (Xu et al., 2016b) investigated a PJI 
in a patient by a combination of transcriptomics and joint fluid metabolomics. The 
study revealed a S. aureus infection thriving on amino acids in a low oxygen 
environment with surprisingly high levels of lactate and ethanol. 
3.1.3. ‘omics’ methods  
To study the metabolic activity within the infecting bacterial biofilm, precise tools 
are necessary. Within the recent years high throughput methods have become 
accessible for identifying processes and regulatory mechanisms that characterise 
the bacterial network in this type of infection. By combining genomics, 
transcriptomics, proteomics and metabolomics, we might be able to gain insight 
into the pathophysiology and virulence factors in biofilm infections (Figure 12). 
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Figure 12 An integrated ”omics” approach for understanding physiology and virulence of 
pathogens (Xu, 2014).  
 
3.1.3.1 Genomics 
Bacteriology has embraced NGS by using whole genome sequencing (WGS). 
Thousands of genomes are being sequenced and high numbers are already 
available for the more frequent bacterial species, allowing us to look into 
pathogenesis, ecology and evolution of the bacterial pathogens.  
Recently Méric and co-workers (Méric et al., 2015) analysed 324 genomes of S. 
aureus and S. epidermidis and showed that gene transfer between the two core 
genomes was rare and only nine such genes were found despite the fact that the 
two species have common niches on the human skin and upper airways. However, 
horizontal gene transfer was more frequent for mobile elements such as 
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pathogenic islands (such as the chromosomal cassette mecA encoding methicillin 
resistance). 
The available genomes provide - via comparative genomics - the basis for further 
development of molecular diagnosis of specific pathogens and are also the 
backbone for studies including transcriptomics and proteomics. 
 
3.1.3.2 Transcriptomics 
The study of transcriptomics gives us insight into the bacterial response to the 
surrounding microenvironment by providing the gene expression profile of 
metabolic pathways as well as stress and virulence factors. It is a snapshot of the 
physiological state of the bacteria, which might reveal the new targets for fighting 
the infection (Waddell et al., 2007). 
Traditionally, DNA microarray has been used for the analysis of gene expression 
profiles of known genes in a fast manner. It has been used for many different 
bacterial species under different conditions in vitro. Isolating bacterial mRNA from 
in vitro cultures is more or less straightforward, but isolating the bacterial mRNA 
from host tissue in sufficient amounts for analysis is a big challenge (Gomez et al., 
2011). The use of DNA microarray is dependent of prior knowledge of the genome 
of interest based on the hybridization to oligonucleotides. High throughput RNA 
sequencing (RNA-Seq) is de novo sequencing which makes it feasible to generate 
millions of sequences independent of primers and thus allowing transcripts of both 
know and unknown sequences to be revealed (Bradford et al., 2010; Croucher & 
Thomson, 2010). Still, the main drawback is the need for millions of cell as starting 
material, which may be difficult to obtain without access to pure cultures. Working 
with clinical specimens the ratio between the amounts of prokaryotic and 
eukaryotic RNA is critical. Only a few studies have managed to study the bacterial 
gene expression profile in vivo in animal infections (Jorth et al., 2013; Szafranska et 
al., 2014; Tong et al., 2016; Yan et al., 2013) and in human infections (Bisharat et 
al., 2013; Lim et al., 2013; Xu et al., 2016b).  
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An example of transcriptomics is described in section 1.9.3.5. In general such 
studies provide a high-resolution genomic analysis of the bacterial pathogen under 
in vivo growth conditions but also provide insight into the metabolic pathways 
required for the bacteria to in survive in the course of infection. 
 
3.1.3.3 Proteomics 
By proteomics the goal is to describe protein expression quantitatively and if 
possible, to follow changes over time and during different conditions. The high 
throughput studies of proteins are basically based on two techniques, two-
dimensional gel-based techniques, where proteins are separated by the isoelectric 
point and mass followed by mass spectrometry (MS). Non-gel based methods apply 
liquid chromatography and tandem mass spectrometry (LC-MS/MS) (Weston & 
Hood, 2004).  
The bacterial proteome has been studied extensively in vitro under different 
conditions. Bénard and co-workers (Bénard et al., 2009) studied differences in S. 
aureus gene expression profile between the planktonic and biofilm state, and they 
found an accumulation of surface-related proteins to be associated with biofilm. In 
vivo studies are more complicated due to the presence of host proteins, which is 
cumbersome to disentangle (Kolmeder & de Vos, 2014) even through several 
studies have managed to study the bacterial proteome in the intestinal tract in 
animals (Alpert et al., 2009; Muth et al., 2013; Roy et al., 2008) and in human body 
fluids (Fouts et al., 2012; Jagtap et al., 2012; Xie et al., 2008). 
As an example, metaproteomic studies in the intestinal tract of mice revealed an 
ability of E. coli to upregulate utilization of several different carbon sources 
simultaneously with culture in vitro serving as a control (Muth et al., 2013). The 
same pattern was also found in Lactococcus lactis in the gastrointestinal tract of 
mice (Roy et al., 2008), and also showed a more diverse metabolism in the in vivo 
model. 
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3.1.3.4 Metabolomics 
The metabolome is the sum of small molecules (<1500 Da) produced by an 
organism and can be seen as the most direct indication of a cell’s metabolic state. 
In addition, novel pathways and quantification of flux within the metabolitic 
network can be explored by use of isotope-labelled metabolites (de Carvalho et al., 
2010). The intracellular metabolism can be studied with intact cells whereas the 
flux of metabolites to the surroundings can be determined from the supernatant. 
Techniques such as nuclear magnetic resonance (NMR) spectroscopy, capillary 
electrophoresis coupled to mass spectrometry (CR-MS), gas chromatography 
coupled to mass spectrometry (GC-MS), and liquid chromatography coupled to 
mass spectrometry (LC-MS) can be used for the study of metabolites (Kell et al., 
2005).  
Metabolomics has been used to study several bacterial species in vitro under 
different conditions and in a complex environment such as the human gut (Aguirre 
et al., 2014; de Graaf et al., 2010). Another study of S. aureus showed differences 
in metabolites between the planktonic state and the biofilm mode of growth. In 
particular, specific markers of biofilm cells were found to be uptake of amino acids 
and a shift to cell-wall synthesis (Ammons et al., 2014). Together with the other 
‘omics’ methods, new knowledge may be acquired for novel strategies in the 
future combat against biofilm infections. 
 
3.1.3.5 Staphylococcus aureus gene expression in vivo 
In paper 4 (Larsen et al., Draft)Paper 4 a guinea foreign-body infection model was 
used (Figure 13) with minor modifications in relation to (Zimmerli et al., 1982, 
1984).  
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Figure 13. Foreign-body infections model in guinea pigs (top) (modified from Zimmerli et al., 
1982, 1984). The guinea pig (female albino guinea pigs, Lidköbing Kaninfarm, Sweden) had 
subcutaneous implantations of four polytetrafluoroethylene (Teflon) cages (32mm X Ø 10 
mm) perforated with 130 spaced holes, Ø 1mm) (Angst-Pfister AG, Zurich, Switzerland) in 
the flanks closed by intercutaneous stitches. Bottom left: Tissue cage before implantation, 
Right: Tissue cage after removal and submerged in RNAlater® (Ambion™, USA). Pictures 
copyright © Lone Heimann Larsen 
 
The choice of the guinea pig animal model was discussed in section 1.9.1 with 
focus of this model’s ability of to better mimic the long-term implant-related 
infection than a mouse or rat model. Traditionally, S. aureus superficial wound 
infections have been studied in guinea pigs, but also implant-related models are 
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established resembling orthopaedic infections and endocarditis (Fischer et al., 
1996; Maurin et al., 1997; Taylor & Lee, 2012). The use of the implant-related 
model gave us the opportunity to investigate the gene expression profile with the 
more advanced RNA-Seq technique. Investigation of expression of single virulence 
genes in S. aureus has previously been done with success in this model (Goerke et 
al., 2001; Senn et al., 2005). One limitation to investigation of infections in guinea 
pigs is intolerance to antibiotics such as penicillin, ampicillin, erythromycin, and 
clindamycin due to a unique combination of intestinal flora with many Gram-
positive bacteria (Hargaden & Singer, 2012). Therefore, the choice of treatment 
was moxifloxacin as being relevant to treatment of S. aureus infections 
internationally (ref.;Henrik C. Schønheyder, personal communication) (Bogner et 
al., 2013), which also have been shown to have an relevant tissue concentration of 
10 mg/mL in guinea pigs one hour after administration per oral (Holzgrefe et al., 
2014). 
 
A S. aureus biofilm was established by directly injection of 2x103 CFU into the tissue 
cages. After 3 days of infection (INF3) fluid was aspirated from the cages for either 
culture to confirm the infection or for transcriptomics. One group of six animals 
received moxifloxacin orally for four days and another group (six animals) did not 
receive any treatment. The animals in the moxifloxacin group were sacrificed on 
day 14 (MOX14), while animals in the non-treated group were sacrificed for ethical 
reasons on day 9 (INF9) as the infection was more aggressive than expected. Both 
cage fluid and the cages were saved either for direct culturing or for 
transcriptomics analysis (for further details see paper 4: Larsen et al. Draft).  
The gene expression profiles showed distant relations to gene expression profiles 
from in vitro culture in LB medium and were closely related to the PJI case study by 
Xu et al. 2016 (Figure 14) (In vitro and PJI raw data are kindly provided by Xu et al. 
2016b). A similar observation has been made for abscesses in humans and mice 
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(Date et al., 2014). Among the in vivo gene expression profiles, the INF9 was the 
closest match to the PJI case, whereas MOX14 resembled INF3. 
Focusing on the in vivo guinea pig infections, the profiles showed genes encoding 
the transcription process rpoB, rpoC and elongation process fusA, tufB were 
expressed in high numbers in all three groups.  
dnaK was also highly expressed in all groups; the gen encodes a co-chaperone 
which is involved in protein folding and especially decreases aggregation of non-
native proteins in the cell and thereby shields the bacteria from intermolecular 
aggregation  (Mayer & Bukau, 2005).  
Whereas the transformation of pyruvate into Acetyl-CoA and formate (pflB gene, 
highly expressed in all groups) is an anaerobic process, other genes resembling an 
aerobic pathway were expressed, i.e. the membrane proteins encoded by cyoB and 
qoxA,  coding for cytochrome bo oxidase, a proton pump which contribute to the 
generation of a proton motive force via reduction of oxygen to water (Puustinen et 
al., 1991). Overall the general picture of the metabolic response of to the 
environment revealed an energy gaining strategy coupled to anaerobic pathways 
(Fuchs et al., 2007) and regulatory responses dealing with an unfriendly 
environment.  
In contract, it was only in the newly established infection (INF3) and after 
moxifloxacin treatment (MOX14) that the genes for the immunoglobulin-binding, 
multifunctional proteins spa and sbi are highly expressed and probably contributes 
to evade the host immune response (Atkins et al., 2008). Conversely, the genes 
isaA and atl encoding for autolysins are highly expressed both in INF3 and INF9. 
These two genes encode enzymes cleaving peptidoglycan, a process that is highly 
active in the exponential phase of growth and they are continuously expressed in 
the stationary phase (Resch et al., 2005). The MOX14 group has a high expression 
of ldh, S-lactate dehydrogenase whereas the INF9 expressed ldhD, R-lactate 
dehydrogenase. This indicate lactate as a source for converting NAD+ to NADH, 
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maybe also from the the host, which correlates to the lactate  permease (lctP) that 
are up-regulated in MOX14. 
 
 
Figure 14. Principal component analysis of all the gene expression profiles. INF3, INF9 and 
MOX14 refer to different time points and exposure in the guinea pig model. Blue: INF3. 
Yellow: INF9. Light blue INF7. Purple: MOX14. Green: Human PJI. Red: in vitro S. aureus 
culture in LB media (Larsen et al., Draft)Paper 4.  
 
In the MOX14 group the dissimilatory reduction of nitrate to ammonium (DRNA) 
pathway was expressed by narG, narH, nreC, narT, and nasD genes (Schlag et al., 
2008), whereas in the INF9 the acetoin biosynthesis was highly expressed by als 
and aldB are (Booth & Kroll, 1983) (Figure 15). Moreover, genes involved in urease 
activity ureABC were all highly expressed, too, and contribute to increase pH 
possible caused of e.g. the productions of ethanol or the accumulation of lactate in 
the anaerobic environment (Korem et al., 2010; Resch et al., 2005). 
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Figure 15. Metabolic pathways differentially expressed in the INF9 (purple) and MOX14 
group(blue) and the commonly expressed pathways (red). Pathways are named according to 
the MetaCyc database. In the bottom, under each pathway the fold change between the 
INF9 (positive) and the MOX14 (negative) are listed, the second collum shows the 
normalised total gene reads for MOX14 and the third shows the normalised mean reads for 
INF9 and the fourth shows the false discovery rate (Larsen et al., Draft)Paper 4. 
 
Despite the different courses of infection in the guinea pig groups the expression 
profiles were remarkably similar and we found few genes to be differentially 
expressed. The metabolic pathways were characteristic for an anaerobic 
environment to which the bacteria adapted by regulating the pH. In general, 
pathways involving pyruvate metabolism were active and maybe this can be a 
vantage point for in future treatment strategies for S. aureus infection 
Chapter 4 Summaries of papers 1-4 
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Paper 1 
Optimizing culture methods for diagnosis of prosthetic joint infections: a summary 
of modifications and improvements reported since 1995.  
Lone Heimann Larsen, Jeppe Lange, Yijuan Xu and Henrik C. Schønheyder 
J. Med. Microbiol. (2012) 61, 309–316. 
 
We did a literature review to provide an overview of improvements made in 
culture-based diagnostic for PJI from 1995-2012. The focus was on transport 
media, specimen types, culture media, and the incubation periods. Due to 
heterogenicity of studies data were presented narratively. 
We found evidence to support superiority of cultures obtained from the diluent 
after sonication of prosthetic implants in comparison with culturing tissue biopsies.  
Culture of synovial fluid in blood culture vials was more sensitive than 
intraoperative swab cultures and tissue cultures. Formal evaluation of agar media 
for culturing PJI specimens seemed to be lacking. The polymicrobial nature of PJIs 
supported the routine use of an assortment of media suitable for recovery of 
fastidious, slow-growing, anaerobic and sublethally damaged bacteria. A number of 
studies supported an incubation period for up to 14 days. As a conclusion we found 
that culturing remains an important means to identify and characterise pathogenic 
microorganisms and supplements the increasing number of culture-independent 
assays. 
 
Paper 2 
 ”All in a box” a concept for optimizing microbiological diagnostic sampling in 
prosthetic joint infections.  
Lone Heimann Larsen, Yijuan Xu, Ole Simonsen, Christian Pedersen, Henrik C. 
Schønheyder, Trine Rolighed Thomsen, and PRIS study group 
BMC Res. Notes, (2014) 7, 418. 
 
At the outset of the PRIS project strict principles were laid out to manage multiple 
sampling in PJI patients, based on experience from a pilot study. The experience 
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gained during the project we published the specimen logistic, as it can be useful 
both for research and clinical practice. Several different surgeons at different 
hospital did the sampling and still we managed to obtain high completeness of our 
specimen sets (approx. 90%). The paper emphasised the need to standardise the 
pre-analytical phase in order to make valid comparisons of different specimen 
types and diagnostic methods. 
 
Paper 3 
Diagnostic value of culture and 16S rRNA sequencing in patients undergoing 
revision surgery for infection of a hip or knee arthroplasty. 
Lone Heimann Larsen, Vesal Khalid, Yijuan Xu, Trine Rolighed Thomsen, Henrik C. 
Schønheyder and The PRIS Study group 
In prep.  
 
Within the framework of the prospective multidisciplinary study PRIS enrolling 
patients with hip or knee prosthetic failures, we assessed the diagnostic 
contribution of different specimen types for PJI and whether 16S rRNA sequencing 
added significant information to culturing. The ultimate goal was to define an 
optimal specimen set. 110 patients underwent 114 revisions (‘cases’) where 
multiple specimens of each type (joint fluid, biopsies of bone and soft tissue, swabs 
from the prosthesis) were obtained besides prosthetic component(s) if removed. 
Additionally, a set of 5 soft tissue biopsies was obtained according to standard 
practice. Culturing was done for 14 days, and 16S rRNA sequencing was performed 
at end of study. A diagnosis of PJI was made in 42 cases: 39 were culture positive 
according to standard criteria; three cases had an entirely clinical diagnosis, 
whereas one additional case was later confirmed by sequencing. We found the 
optimal specimen set to include joint fluid, five soft tissue biopsies, and prosthetic 
components. In aggregate, positivity of the optimal set concorded well with the PJI 
diagnosis (93%; 39/42) despite a lower concordance for individual specimen types. 
In the light of an optimised culture diagnostic, the significant contribution of 16S 
rRNA sequencing were less importance and must only be applided on selected 
patients with low-term chronic cases. 
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Paper 4 
Staphylococcus aureus gene expression profiles in a guinea pig biofilm infection 
model: Effect of time and antibiotic treatment with moxifloxacin. 
Lone Heimann Larsen, Yijuan Xu, Kåre L. Nielsen, Henrik C. Schønheyder and Trine 
Rolighed Thomsen 
Draft 
 
We established a S. aureus foreign-body infection model in guinea pigs. Specimens 
were taken after 3 days (INF3), and subsequently one group was treated orally with 
moxifloxacin for 4 days, and a second group did not receive treatment. The treated 
group was sacrificed at day 14 (MOX14), while the untreated group was sacrificed 
on day 9 (INF9). The gene expression profiles were analysed for all tree groups and 
were remarkable similar despite the different course of infection. The gene 
expression profiles also concorded well with the human PJI infection being the 
source of same strain. The data shows anaerobic pathways to predominate and 
pyruvate metabolism in particular. Different strategies were activated in order to 
handle the acidic environment, and this may be a vantage point for future 
treatment strategies for S. aureus infection. 
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Case: In 1994 a patient had a total knee replacement, followed shortly 
by an insertion of a cemented patella component. Throughout the years 
he had continuously pain and in 2005 he contacted the hospital again 
with severe pain, instable prosthesis. The diagnostic imaging revealed 
synovitis, which was deemed to be related to an on going 
rheumatologic disease. A revision was carried out with replacement of 
the prosthesis but the patella component was retained.   
The culturing revealed coagulase-negative staphylococci in 3 out of 5 
synovial biopsies and the patient was put on treatment with antibiotics. 
After the revision the patient recurrent stress-related pain, swelling of 
the knee and a slight, but persistent elevation of inflammatory markers. 
Repeated joint aspirations in 2006 were negative on standard culture. 
The patient was treated with a brief course of steroids.  
In 2012, the patient had persistent stress-related pain and swelling of 
the knee. The patient was included in the PRIS project and advanced 
diagnostic nuclear imaging showed a ‘hotspot’ at the interface between 
the lateral tibia plateau and the prosthesis. The prosthesis was removed 
and submitted to extensive microbiological diagnostics. The 
microbiology showed S. epidermidis with an antibiogram similar to that 
reported in 2005, making it very likely that a chronic biofilm prosthesis 
infection had persistent for the last 7 years. The patient was treated 
with antibiotics and the infections parameter was normalised for the 
first time since 1994. 
Larsen et al. Eurobiofilm 2013, Genth, Belgium (Larsen et al., 2013) 
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The above-mentioned case is one example of the importance of improvement of 
our knowledge related to PJI and to improve the diagnosis to avoid long-term 
painful courses of illness.   
 
To improve the diagnosis and treatment of PJI, the first priority is to recognise the 
microorganism/s by using the best combination of specimens and diagnostic 
methods. No single specimen type or diagnostic method has yet been proven to 
cover the entire variety of PJI patients. Secondly, new treatment strategies are 
warranted, especially for the biofilm related infections. A better understanding of 
how microorganisms behave in biofilm infection may contribute to revelling points 
of interest. Therefore, one of the aims of this PhD project was to characterise the 
clinical diagnostic challenge of PJI and to evaluate well-established diagnostic 
methods together with explorative methods, for investigation of the microbial 
diversity in implant-related infections. Moreover, the work with the guinea pig 
biofilm infection model and transcriptomics would provides insights into the S. 
aureus biofilm infections in vivo and especially where the biofilm infections may be 
most vulnerable for therapeutic interventions, the metabolistic pathways which 
are vital for the bacterial survival in a hostile host environment. 
 
Biofilm infections are difficult to diagnose due to the adherence of bacteria to the 
implant and the implant needs to be removed for an identification of the 
microorganism and diagnosis. Failure to detect biofilm bacteria can have significant 
consequences. Undiscovered bacteria either caused by polymicrobial infections or 
false negative diagnostics can lead to only partial coverage by antibiotic. When the 
treatment are chosen in accordance with results obtained by standard cultures and 
it may even lead to mistaking a PJI for aseptic failure. Besides consequences for the 
individual patient, such mistakes may lead to biased assessment of prosthetic 
failures overall. Thus, surgical intervention serves the dual purpose of providing 
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diagnostic specimens from relevant sites and to clear out recalcitrant biofilm 
infections. To have the relevant specimens is crucial for the optimal diagnosis, and 
we tested a logistic concept with several different specimen types in the relevant 
clinical settings and managed to receive 90% of all planned specimens. This 
concept was the foundation for the subsequent evaluation of which bacteria were 
present in the PJIs. A second obstacle for the diagnosis of PJI is the low growth rate 
of bacteria in biofilm and the need to ‘awake’ the persisters, requirements that are 
not necessarily met by standard culture methods. The standard method for 
culture-based diagnostic is soft tissue biopsies both in Denmark and internationally 
as outlined in recent international guidelines. However, since 1999 the use of 
sonication diluents from prosthetic component has been shown to increase the 
diagnostic sensitivity of culture methods. A part of this contribution is awakening 
of persisters in the biofilm. Even though new specimen types show promising 
results, no single one has been proven to cover all PJI patients. Thus, the optimal 
microbial diagnosis of PJI requires a combination of specimens and methods rather 
than a single specimen and method at present. We showed that a specimen 
collection of joint fluid, multiple soft tissue biopsies, and the prosthetic component 
fulfils this task and is superior to the time-honoured reference standard of multiple 
tissue biopsies. The merit of the specimen set is expedience and accuracy of 
diagnosis, and it overcomes the heterogeneous distribution of biofilms in PJI. 
 
Our optimised culturing with a broad range of media and prolonged incubation 
times was superior to molecular methods in cases with acute infection with easily 
culturable bacteria and can provide a preliminary diagnosis within one – two days. 
But for the more challenging cases suspected of chronic infection, the use of 
molecular techniques based on PCR and sequencing can supplement results 
obtained by culture and are likely to provide a faster diagnosis in optimised 
diagnostic settings. 
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The uses of molecular techniques have shown promising results in the literature, 
and especially multiplex PCR has proven to contribute to the diagnosis of PJI, but 
only in research settings. Recently, a large multicentre study concluded that the 
use of PCR based diagnostics did not contribute significantly to the diagnosis of PJI 
used on all types of patients. These results are in line with the results from the PRIS 
study reported in this thesis, we suggested that molecular technique shut be 
restricted tor a special group of patients until more effective methods are 
developed for the diagnosis of PJI. For the time being molecular techniques can be 
reserved for patients in whom the diagnosis might be challenging and for specific 
specimen types. 
 
Being a relatively young field of research, many unresolved questions exist 
regarding the pathogenesis and colonisation strategy of the bacteria involved. 
Werner Zimmerli has pointed out that spontaneously healing of a implant-related 
infection has never happened – so “knowing the enemy” must be one of the next 
steps for finding the possible weak spots for an offensive. Experience from the 
clinical setting and laboratory experiments need to be supplemented with in vivo 
experiments in order to get more insight into the world of biofilm and to 
disentangle the complexity. A crucial point is to analyse the behaviour on a 
molecular level, hopefully identifying backdoors for eliminating implant-related 
infections without a surgical intervention in the future.  
The uses of a model system have to be chosen carefully in respect to the question 
together with the approaches used for analysis. The different ‘omics’ approaches 
can be applied, each gives insight into different levels of the metabolic 
possibilities/activities in infection, these techniques can help to answer some of 
the questions and help enlighten some of the complex interactions.  
The use of transcriptomics for the study of an in vivo model resembling an implant-
related infection gave us insights into some of the complex regulatory mechanisms 
in a S. aureus infection and the regulation and adaptation to the anaerobic and 
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acidic environment, confirming findings in a pilot study of a human PJI. The 
discovery of highly expressed metabolic pathways centred around pyruvate 
metabolism and different strategies are applied for regulation of pH, which gave us 
points of interest. With further investigation of infections in vivo and better 
understanding of metabolic regulation together with the already published 
knowledge regarding virulence factors and biofilm control, this might lead us to 
new targets in the fight against microorganism and the biofilm form of life. 
 
 
In the dream setup for the diagnosis and treatment of PJI patients, surgical 
intervention would be obviated. Treatment would eradicate the infecting 
microorganisms irrespective of biofilm formation. Still, there is a long way to go, 
but progress in a smaller scale would be welcome. With an improved diagnosis of 
PJI and an increasing understanding of the pathogenesis in the bacterial biofilm, 
better treatment might be one step closer. 
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Improving diagnosis of prosthetic joint infections (PJIs) has become an increasing challenge due
to a steadily rising number of patients with prosthetic implants. Based on a systematic literature
search we have ascertained the evidence base for improvement of culture diagnosis. We
searched PubMed/MEDLINE using the medical subject heading (MeSH) ‘prosthesis-related
infections’ 1995 through 2010 without further restrictions. An analogous search was conducted
for ISI Web of Knowledge. A total of 1409 reports were screened for original results, obtained by
methods described in sufficient detail to make replication possible. We gave priority to methods
for sample preparation, culture media, culture methods and incubation time. Clinical sensitivity and
specificity were calculated where possible. We found evidence to support superiority of cultures
obtained from the diluent after sonication of prosthetic implants in comparison with culturing
tissue biopsies. Sonication parameters and accessory steps have been studied extensively, and
thresholds for significant growth have been defined. Conversely, methods for processing of soft
tissue biopsies have been studied to a limited extent. Culture of synovial fluid in blood culture vials
has been shown to be more sensitive (90–92%) than intraoperative swab cultures (68–76%)
and tissue cultures (77–82%). Formal evaluation of agar media for culturing PJI specimens
seemed to be lacking. The polymicrobial nature of PJIs supports the routine use of an assortment
of media suitable for recovery of fastidious, slow-growing, anaerobic and sublethally damaged
bacteria. A number of studies supported an incubation period for up to 14 days. Although we
identified evidence-based improvements of culture methods, there is a need for more studies
especially with regard to tissue biopsies. Culturing remains an important means to identify and
characterize pathogenic micro-organisms and supplements the increasing number of culture-
independent assays.
Introduction
Joint replacement has become one of the most common
surgical procedures in industrialized countries and con-
tributes significantly to the mobility and quality of life of
elderly people. Even with the best precautions, prosthetic
joint infections (PJIs) do occur and they have become a
significant burden on orthopaedic services due to the sheer
number of patients with hip and knee prostheses. The
clinical spectrum of PJIs is variable and includes both overt
and silent infections, and bacterial pathogens are envisaged
to have a role in ‘aseptic’ loosening (Zimmerli et al., 2004;
Zappe et al., 2008; Pedersen et al., 2010).
For these reasons, diagnostic methods have received
increasing attention. A range of molecular techniques have
been introduced primarily as research tools and a new
concept of PJIs is gradually emerging (McDowell & Patrick,A supplementary table is available with the online version of this paper.
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2005; Achermann et al., 2010). Bacteria common in PJIs
are typically organized in a biofilm, which is a micro-
bial community enclosed within an extracellular matrix
(Donlan, 2002). The normal microbiota of the skin is the
most common source of bacteria detected in PJIs, and 16S
rRNA gene sequence-based methods have revealed infec-
tions to be polymicrobial in line with results achieved by
standard culture methods in some studies (Tunney et al.,
1999; Moojen et al., 2007).
Despite the increased utilization of molecular techniques,
culture methods are indispensable for determination of
antibiotic susceptibility and they are an important means
of confirming results obtained by culture-independent
methods. Kamme & Lindberg (1981) were the first to
report separate sampling and processing of multiple tissue
biopsies taken in proximity to hip prostheses as a means
of increasing the accuracy of infection diagnosis. Over
the years, a number of studies have addressed different
methodological issues that may have an impact on the yield
of positive cultures. However, to our knowledge, few
attempts have been made to systematize and critically
assess such methods (Gollwitzer et al., 2006).
Several overviews of the biochemistry, clinical diagnosis
and treatment of PJIs have recently been published (Senthi
et al., 2011; Gomez & Patel, 2011a, b). Still, there is a need
for a more detailed assessment of methods for sample
preparation, culture media, culture methods and incuba-
tion time. The aim of this review was to determine the best
practices for improvement of culture diagnosis of PJIs.
Methodological approach
A search of ISI Web of Knowledge and the US National
Library of Medicine’s MEDLINE database was conducted
for relevant articles. Access to MEDLINE was through
PubMed, using the medical subject heading (MeSH term)
‘prosthesis-related infections’ (introduced 1992) with the
subheading ‘microbiology’ and a restriction to the years
199522010 (date of search 15 January 2011). No restric-
tion was made to orthopaedic infections because meth-
odological studies addressing other prosthetic infections
were seen as potentially relevant.
A total of 1409 articles were screened initially by title and
subsequently by the contents of the abstract and the section
on material and methods. We specifically sought informa-
tion on modification, improvement or optimization of
diagnostic methods as well as detailed descriptions of sample
preparation and culture methods, including incubation
time. Further references were obtained from reference lists.
For each eligible article, we collected the following infor-
mation: year of publication, researcher/research group,
design (observational study vs clinical trial, prospective
vs retrospective study, comparative vs non-comparative
study), diagnostic criteria for PJI, method(s) evaluated,
reference method (‘gold standard’) if any, unit of obser-
vation (patients, samples, bacterial isolates), report format
(cross tables or aggregated figures) and accuracy [sensitivity,
specificity, positive and negative predictive values (PPV and
NPV)].
Few studies did fulfil basic criteria for a systematic review.
The most pertinent problems were lack of a gold standard
and independent evaluation of results. Statistical analyses
of results were often unclear and units of observation
differed between (and sometimes within) studies. Where
possible, we assessed test performance based on numbers of
patients, and we defined the sensitivity of a given method
as the number of PJI patients with a positive culture
divided by the number of PJI patients examined by that
method. Likewise, specificity was defined as the number of
patients without PJI who had a negative culture divided
by the number of non-PJI patients examined by the meth-
od. In order to compare the accuracy of methods, we
calculated exact 95% confidence limits for proportions
[(#;#)] (Stata 11, College Station, Texas, USA).
Current approaches
Transportation systems
We found no studies evaluating the performance of
transport media with orthopaedic samples. A non-com-
parative study used broad-necked containers with Stuart
transport medium for surgical biopsies from patients under-
going prosthetic joint revision (Mikkelsen et al., 2006).
However, several studies evaluated the performance of
transport media with cultures of fastidious and robust
aerobic and anaerobic bacteria according to the M40-A
standard (Clinical and Laboratory Standards Institute)
(CLSI, 2003; Rishmawi et al., 2007; Van Horn et al., 2008;
Stoner et al., 2008; Tano & Melhus, 2011). Performance
differed depending on temperature, holding time and
bacterial strains. In general, good preservation was reported
for media held at 4 uC but the results varied at room
temperature. Results obtained with simulated polymicro-
bial samples were less predictable (Tano & Melhus, 2011).
Transport systems with Amies medium or variations thereof
maintained viability better than Stuart medium, but pro-
moted growth of some bacteria (Tano & Melhus, 2011).
Tunney et al. (1998, 1999) used anaerobic jars for trans-
portation of prosthetic components from the surgical theatre
to the laboratory followed by strict anaerobic processing of
samples. Anaerobes accounted for a high proportion (62%)
of isolates from the prosthetic components.
Sample preparation
PJI samples comprise frank pus, purulent fluids, synovial
fluid, synovia and/or other soft tissue samples, bone biop-
sies, prosthetic components or entire prostheses.
Different treatments are applied to the samples before
inoculation takes place, either to dislodge bacteria from a
matrix or to increase the density. Several studies have
addressed such preparatory steps.
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Synovial fluid. Techniques primarily developed for blood
culturing have been pivotal for processing of synovial fluid
in PJIs. Paediatric blood culture vials were reported to
detect more pathogens than agar plate methods (62 vs 51
pathogens; P50.001) with fewer contaminants (1 vs 11
contaminants; P50.006) (Hughes et al., 2001). The authors
related the contaminants to handling and inspection of
agar plates.
Two studies compared culturing of synovial fluid with
surgical swabs or tissue biopsies in patients with PJIs using
direct inoculation of aerobic and anaerobic blood culture
vials for synovial fluid and agar plates for swabs or biopsies
(Levine & Evans, 2001; Font-Vizcarra et al., 2010). Both
studies showed higher sensitivity and specificity for direct
inoculation although the precision was low (Table 1).
Melhus & Tjernberg (2000) evaluated three different blood
culture vials (two anaerobic and one paediatric) for
recovery of anaerobic bacteria in a simulation study with
10 bacterial strains. They found differential growth of
anaerobic bacteria in blood culture vials and thioglycolate
broth whereas chopped meat broth (a traditional anaerobic
medium) performed well.
Swab cultures. Culturing of superficial swabs from wound
drainage has a traditional place in the diagnosis of deep
bacterial infections (Mackowiak et al., 1978). Cuñé et al.
(2009) evaluated such cultures in patients with acute
postoperative PJI and found isolation of Staphylococcus
aureus and enteric rods highly predictive of the aetiological
organism (PPV .86%, NPV .94%).
As shown in Table 1, intraoperative swab cultures had a
lower sensitivity compared with culturing of synovial fluid
and tissue biopsies according to the study by Font-Vizcarra
et al. (2010). Of note, we did not find studies that
addressed the performance of different types of swabs in
orthopaedic infections.
Soft tissue samples. The literature search did not reveal
comparative studies on the preparation of tissue samples
for microbial cultures. Three different preparation methods
were applied for tissue samples: (1) partitioning into smaller
pieces with a surgical knife (Mikkelsen et al., 2006), (2)
grinding with a mortar and pestle or (3) stomaching.
Homogenization by use of mortar and pestle was applied
in several studies (Günthard et al., 1994; Levine & Evans,
2001). Günthard et al. (1994) reported two cases of
endocarditis with negative cultures by direct plating of
cardiac tissue, but positive cultures matching previous
blood cultures after homogenization with the Ten Broeck
tissue grinder.
The Stomacher technique was applied for PJI samples in a
study addressing Propionibacterium acnes in particular
(Butler-Wu et al., 2011). The release of cultivable bacteria
by this technique has recently been evaluated in food
microbiology (Hannah et al., 2011). T
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Solid samples and prosthetic components. Culturing of
bone biopsies has rarely been reported in studies on PJIs.
Conversely, there is an extensive literature on processing of
prosthetic materials by sonication. Tunney et al. (1998)
applied mild sonication [5 min, 50 kHz, corrected by
McDowell & Patrick (2005)] to dislodge bacteria adherent
to the implants and reported an improved detection of
infective agents in hip PJIs. A number of subsequent studies
confirmed a higher yield by this method (Table 2) (Trampuz
et al., 2006, 2007; Bjerkan et al., 2009; Monsen et al., 2009;
Piper et al., 2009). Sonication was evaluated in experiments
with bacterial cultures relevant to PJIs, indicating, especially
for Gram-negative bacteria, a trade-off between dislodge-
ment of bacteria and decreased viability. According to
Monsen et al. (2009), the duration of sonication and the
material of the tube were critical parameters for the
cultivability of bacteria after treatment. They recommended
the following parameters for sonication: 40 kHz for 7 min at
22 uC in order to provide maximum effect and preserve
viability of Gram-negative bacteria. No further improvement
was observed by lowering the temperature. Thin-walled glass
tubes provided an increased effect compared to plastic tubes.
Furthermore, Monsen et al. (2009) compared sonication in
tubes deeply submerged in the sonication bath with
sonication in tubes only partially submerged (~25%), and
they found a similar effect as long as the sample in the tube
was completely submerged in the diluent.
By sonication bacteria are released into the diluent, and a cen-
trifugation step can be required for concentrating bacteria into
a smaller volume. When processing entire prostheses the volu-
me of diluent makes centrifugation of aliquots the most prac-
tical way to proceed (Monsen et al., 2009; Piper et al., 2009).
Newly published studies indicated that vortexing of the
sample for 30 s before and after sonication may in-
crease the yield of positive cultures (Trampuz et al., 2007;
Kobayashi et al., 2009; Sampedro et al., 2010).
In a thorough study of a patient with PJI, Sendi et al. (2010)
observed phenotypic variation of Escherichia coli recovered
from periprosthetic biopsies and from the diluent after soni-
cation of the entire prosthesis. These small-colony vari-
ants (SCVs) were clonally indistinguishable from E. coli with
normal morphological features. Cultures from synovial fluid
showed colonies with the normal phenotype only. With
further subcultivation the SCV E. coli adapted to the normal
phenotype. The authors concluded that the different pheno-
types most likely originated from different niches, i.e. the
biofilm on the prosthesis and the synovial fluid. Proctor et al.
(2006) did also bring attention to this issue with reference to
S. aureus isolates surviving within mammalian cells: SCV S.
aureus has an impaired growth rate and unusual biochemical
characteristics that may hamper its correct identification.
Culture media
The media commonly used for PJI samples are non-
selective and enriched with a content of blood or blood T
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products. However, studies rarely provided detailed infor-
mation on culture media. In Supplementary Table S1 in
JMM Online, we have listed papers which provided suffi-
cient details as well as a list of bacterial isolates. To our
knowledge, no studies have formally evaluated the perform-
ance of different agar media in the diagnosis of PJIs.
A differential effect of the culture medium was noted by van
Kats et al. (2010) in a study of heart valve biopsies. The
transport medium was inoculated both into blood cul-
ture vials (FA and FN blood culture media, BacT/Alert;
bioMérieux) and thioglycolate broth. Coagulase-negative
staphylococci and Propionibacterium species were isolated
in higher frequencies with thioglycolate broth than with
blood culture vials, and vice versa for S. aureus. Similarly,
thioglycolate broth was reported to promote growth of a
broader range of anaerobic bacteria than anaerobic blood
culture vials in an experimental study mentioned previously
(Melhus & Tjernberg, 2000). The use of pre-reduced culture
media and strict anaerobic techniques has been emphasized
in some studies addressing optimization of diagnosis of PJI
(Tunney et al., 1998, 1999; McDowell & Patrick, 2005).
Nevertheless, not only can the type of medium have an
effect on bacterial cultivability but also the viscosity impacts
on the spectrum of micro-organisms isolated (Wyatt &
Archer, 1988).
Incubation
The papers listed in Supplementary Table S1 reported
incubation periods from 2 to 14 days and this broad range
applied to both aerobic and anaerobic cultures. In the
majority of studies, the incubation period was in the order of
5 days for aerobic cultures and 7 days for anaerobic cultures
(Trampuz et al., 2007; Piper et al., 2009; Achermann et al.,
2010). According to Schäfer et al. (2008), prolongation of
the incubation period was associated with an increase in the
proportion of positive samples and diversity of bacterial
isolates (Table 3). In line with this, Schäfer et al. (2008)
recommended an incubation period of up to 14 days based
especially on late recovery of aerobic Gram-positive rods,
Propionibacterium species and Peptostreptococcus species. In
the aforementioned study by Günthard et al. (1994), growth
of P. acnes was reported to require more than 8 days, and,
similarly, Butler-Wu et al. (2011) found a 29% increase in
cultures positive for P. acnes when comparing a 13 day
incubation period with 7 days. Likewise, an incubation
period of 14 days was used by Sendi et al. (2010) for
recovery of SCV E. coli.
Skovby et al. (2011) described a practical scheme for
extending the incubation of PJI cultures beyond day 5 by
subculturing of visually negative semi-solid thioglycolate
media onto appropriate agar plates, which were evaluated
on day 12. The scheme resulted in a 10% increase in
bacteriological findings deemed to be clinically significant.
Quantitative aspects of cultures
In their study on multiple biopsies in prosthetic hip
infections, Kamme & Lindberg (1981) were primarily
concerned with contamination during sampling, trans-
portation and handling in the laboratory. The biopsies
(n55) were taken from the same area adjacent to the
cement or prosthesis guided by suspicion of infection or
bone resorption. In 10 of 31 control arthroplasties, one or
two biopsies were positive per set [P. acnes accounted for 9
(69%) of 13 bacterial isolates]. On this basis, the authors
defined ¢three positive biopsies as significant growth. To
our knowledge, this criterion has only been evaluated once,
namely in a retrospective Danish study comprising 118
patients with knee prosthetic joints [specificity 100% (94;
100); sensitivity 46% (27; 67)] (Mikkelsen et al., 2006).
Atkins et al. (1998) undertook a prospective evaluation
of microbiological diagnostic criteria of PJIs and found
growth of an indistinguishable micro-organism from cul-
tures of at least three independent specimens (biopsies and
synovial fluid included) to be highly predictive of infection
(sensitivity 65%, specificity 99.6%). A caveat to this study
was the fact that the sampling strategy varied somewhat
between patients. By mathematical modelling, ¢five
specimens was found to be the optimal number of samples
in order to minimize false-negative outcomes.
In accordance with the two former studies, Schäfer et al.
(2008) obtained sets of five biopsies of both periprosthetic
tissue and the synovial membrane in PJIs (hips and knees
included). They deemed ¢two biopsies with indistinguish-
able growth to indicate infection, but made a concession
to one positive culture in cases with acute inflammation
diagnosed by histopathological examination.
A different aspect of multiple samples was highlighted
by Zappe et al. (2008), who investigated the role of
Propionibacterium species in PJIs. The study analysed eight
patients who formed a subset from a larger study, and all
but one had multiple positive samples (median proportion
of positive samples 39%, interquartile range 18–55%). The
mean number of biopsies was 9.5 in cases with positive
Table 3. Proportion of samples with early and late growth during prolonged incubation
No of samples; patients Incubation period (days) Early detection of growth
(¡7 days)
Late detection of growth
(.7 days)
Schäfer et al. (2008) S: 284; P: 110 14 73% 27%
Butler-Wu et al. (2011) S: 557; P: 173 13 71% 29%
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cultures and the authors stressed the importance of
multiple samples, especially for patients treated with
antibiotics before surgery.
Towards more efficient diagnostics
Review of the literature has identified a number of options
for improvement of culture diagnosis in patients with
PJI. During the last 15 years, there has been a growing
understanding of the role of polymicrobial infection and
biofilm formation in PJIs and this has been a challenge to
time-honoured culture methods. The causative microbiota
originates predominantly from the skin, and many of these
micro-organisms show different phenotypes with varying
cultivability (Donlan, 2002; Proctor et al., 2006).
The key areas for evidence-based improvements were the
following:
$ collection of multiple samples from the site of
infection;
$ selection of the transportation system;
$ inoculation of synovial fluid directly into blood
culture vials;
$ culture of sonication diluent after sonication of
prosthetic components if necessary combined with a
centrifugation step;
$ prolongation of incubation of cultures for up to
14 days.
The crucial number of positive specimens is still debatable
as Kamme & Lindberg (1981) and Atkins et al. (1998) both
settled for three independent specimens to confirm a
diagnosis of PJI, but Schäfer et al. (2008) required only
two.
The importance of transportation of specimens from the
operation room to the laboratory seems to have been
underestimated but so far surrogate studies with bacterial
cultures have indicated Amies medium and variations
thereof to be reliable within a time frame of 24 h
(Rishmawi et al., 2007; Van Horn et al., 2008; Stoner
et al., 2008; Tano & Melhus, 2011). A cool (4 uC) transport
chain may not be vital as the studies quoted showed
acceptable preservation of viability at room temperature.
An effective protocol has been devised for sonication of
prosthetic material (Fig. 1) and significant growth has been
defined in terms of c.f.u. per entire implant or per volume
of sonication diluent.
The direct inoculation of synovial fluid in blood culture
vials has been proven to increase rates of positive cultures
deemed clinically significant and to reduce contamination
as compared with plate cultures (Hughes et al., 2001).
However, the optimal choice of blood culture medium and
aerobic versus anaerobic conditions is open for discussion
(Melhus & Tjernberg, 2000).
In a review of culture techniques for biofilms, Høgdall et al.
(2010) emphasized that many bacteria may be inactive,
dormant or damaged by sonication during sample prepara-
tion. The time range until colonies can be recognized on
agar plates can therefore be very prolonged (Høgdall et al.,
2010). These observations are compatible with an incuba-
tion period of up to 14 days as suggested by both Schäfer
et al. (2008) and Butler-Wu et al. (2011).
Conclusions and perspective
Only a few diagnostic studies on PJIs fulfilled rigid criteria
for a systematic review. The most pertinent problems were
lack of an independent reference standard and inclusion of
patients because their samples had been processed with the
evaluated method (STARD Statement 2008). ‘Best evi-
dence’ was therefore based primarily on concordant results
from different researchers. The robustness and accuracy of
methods coming from the research laboratory should be
confirmed in the routine clinical setting before they
become standard practice. With the increased handling of
PJI samples, one of the concerns is the increased risk of
contamination. Various precautions can be taken including
handling of samples and cultures in a laminar air flow
bench (Schäfer et al., 2008), separate incubators for
prolonged incubation and, in general, keeping inspections
to a minimum.
Fig. 1. Effective protocol for sonication of prosthetic material.
Limits for interpretation of growth: ¢20 c.f.u. per plate [¢20 c.f.u.
(10 ml Ringer’s solution)”1]. Ringer’s solution was used by
Trampuz et al. (2007), Monsen et al. (2009) and Sampedro
et al. (2010). Ringer’s solution (25%, v/v) containing L-cysteine
(0.05%, w/v) as a reducing agent for optimal isolation of P. acnes
was used by Tunney et al. (1998, 1999). According to Tunney
et al. (1998, 1999), Trampuz et al. (2007), Monsen et al. (2009),
Sampedro et al. (2010), Gomez & Patel (2011b).
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In future studies, it will be important to correlate results
obtained by culture with those obtained by culture-
independent methods (Tunney et al., 1999; Panousis
et al., 2005; McDowell & Patrick, 2005; Achermann et al.,
2010) and thereby possibly define a new reference standard.
Techniques for processing of biopsies of soft or solid tissue
should be studied in the same diligent way as sonication of
prosthetic implants, as the studies showed that the effective
dislodgement of bacteria can increase the sensitivity. Tissue
grinding has proved useful for other areas of microbiolo-
gical research (Günthard et al., 1994) and should be tested
preferably with single use equipment.
The time-honoured concept of broad-range bacteriological
media seems still to be valid considering the multiple
bacterial species associated with PJI. Whether supplemen-
tary or new media can augment the yield of cultures is
not clear. The polymicrobial nature of many PJIs makes
control of overgrowth by, for example, coagulase-negative
staphylococci an important consideration. The use of
selective media must be given due consideration.
As mentioned briefly, the viscosity of the medium may
have an impact on the culturability of planktonic and
biofilm-adapted bacterial phenotypes. This speaks in
favour of semi-solid media such as thioglycolate agar and
semi-solid nutrient agar (Tittsler & Sandholzer, 1936).
Both antibiotic treatment before surgery and the prepara-
tory steps can lead to sublethal damage of bacteria and
thereby have a negative impact on culture results. Culturing
techniques drawing on experience from food microbiology
(Wu, 2008) together with culture-independent techniques
may help improve diagnosis under these circumstances.
Attention to strict anaerobic precautions during trans-
portation and processing of samples is a key area for
improvement of diagnosis of PJIs (Summanen et al., 1993;
Tunney et al., 1998, 1999). Based on the current literature,
it is tempting to see the isolation rate of P. acnes as the best
indicator of the proficiency of anaerobic cultures.
Ultimately, one must bear in mind that many bacteria
are not cultivable despite all attempts to optimize culture
methods; the cultivable fraction from human skin or oral
cavity is around 16–20% of the total diversity and even lower
for environmental bacteria (,1%) (Amann et al., 1995;
Kroes et al., 1999; Gao et al., 2007). To complicate matters
further, growth of some bacteria may depend on other species
and therefore they cannot be isolated in pure culture (Amann
et al., 1995).
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Supplementary Table S1. Culture media and incubation periods used for prosthetic joint infections 
Studies of prosthetic joint infections with detailed information on culture media and bacterial isolates. Most studies also 
reported the incubation period. NS, Not stated. 
 
Culture media (supplier) Conditions Incubation 
period (days)
Reference
Blood culture flask, aerobic, paediatric 
and anaerobic (BACTEC 9240 system; 
BD and BacT/ALERT; bioMérieux)
Aerobic, anaerobic 5–7 Levine & Evans (2001); Font-Vizcarra 
et al. (2010); van Kats et al. (2010)
Thioglycolate broth (unknown) Aerobic 3–5 Neut et al. (2003); Font-Vizcarra et al. 
(2010)
Thioglycolate (BioTrading Benelux) Aerobic 14 van Kats et al. (2010)
Thioglycolate broth (BD) Aerobic NS Levine & Evans (2001)
Tryptone Yeast Glucose (TYG) broth 
(Oxoid)
Anaerobic NS Farrar et al. (2007)
Brain heart infusion broth (Oxoid) Aerobic 14 Schäfer et al. (2008); Sendi et al. (2010)
Schaedler broth (Oxoid) Anaerobic 14 Schäfer et al. (2008)
Fastidious broth (BD?) Aerobic NS Levine & Evans (2001)
Blood agar (unknown) Aerobic 2–5 Neut et al. (2003); Font-Vizcarra et al. 
(2010)
Blood agar (unknown) +0.5% haemin 
+0.1% menadione
Aerobic, anaerobic 7 Neut et al. (2003)
Hemoline blood agar (bioMérieux) Aerobic, anaerobic 7 Zeller et al. (2007)
Trypticase Soy Broth agar, 5% sheep 
blood (Oxoid)
Aerobic 14 Schäfer et al. (2008)
Sheep blood agar (BD) Microaerobic, 
anaerobic, aerobic
4–14 Levine & Evans (2001); Trampuz et al. 
(2006); Piper et al. (2009); Font-
Vizcarra et al. (2010)
Columbia sheep blood agar 
(bioMérieux)
Aerobic 14 Sendi et al. (2010)
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Anaerobic blood agar (BD) Anaerobic NS Levine
Chocolate agar (unknown) 5% CO2 7 Zeller et al. (2007)
Chocolate agar (unknown) Aerobic 2–4 Neut et al. (2003)
Chocolate agar (BD) Aerobic Up to 14 Levine & Evans (2001); Schäfer et al. 
(2008); Sendi et al. (2010)
Schaedler agar (unknown) Anaerobic 5 Font-Vizcarra et al. (2010)
Schaedler agar (bioMérieux) Anaerobic 7 Zeller et al. (2007)
Schaedler agar +K1, 5% sheep blood 
(BD) (P. acnes)
Anaerobic 14 Schäfer et al. (2008)
MacConkey II agar (BD) Aerobic 4–14 Levine & Evans (2001); Schäfer et al. 
(2008)
Reinforced clostridial agar (Oxoid) Anaerobic NS Farrar et al. (2007)
Brucella agar (BD) Anaerobic 5–14 Neut et al. (2003); Sendi et al. (2010)
Colistin nalidixic acid (CAN) (BD) Aerobic NS Levine & Evans (2001)
Anaerobic phenyl-ethyl alcohol agar 
(BD)
Anaerobic NS Levine & Evans (2001)
Anaerobic laked kanamycin-
vancomycin agar (BD)
Anaerobic NS Levine & Evans (2001)
Tryptone Yeast Extract Glucose 
(TYEG) agar+2 μg furazolidone ml 1 
(Oxoid)
Anaerobic 7 Ross et al. (2003)
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Abstract
Background: Accurate microbial diagnosis is crucial for effective management of prosthetic joint infections.
Culturing of multiple intraoperative tissue samples has increased diagnostic accuracy, but new preparatory
techniques and molecular methods hold promise of further improvement. The increased complexity of sampling is,
however, a tough challenge for surgeons and assistants in the operation theatre, and therefore we devised and
tested a new concept of pre-packed boxes with a complete assortment of swabs, vials and additional tools needed
in the operating theatre for non-standard samples during a clinical study of prosthetic joint infections.
Findings: The protocol for the clinical study required triplicate samples of joint fluid, periprosthetic tissue, bone tissue,
and swabs from the surface of the prosthesis. Separate boxes were prepared for percutaneous joint puncture and surgical
revision; the latter included containers for prosthetic components or the entire prosthesis. During a 2-year project period
164 boxes were used by the surgeons, 98 of which contained a complete set of samples. In all, 1508 (89%) of 1685
scheduled samples were received.
Conclusion: With this concept a high level of completeness of sample sets was achieved and thus secured a valid basis
for evaluation of new diagnostics. Although enthusiasm for the project may have been a contributing factor, the
extended project period suggests that the ‘All in a box’ concept is equally applicable in routine clinical settings with
standardized but complex diagnostic sampling.
Keywords: Prosthesis, Infections, Specimen handling, Specimen types, Transport media
Findings
Background
The microbiological diagnosis plays a crucial role in the ef-
fective management of patients with suspected prosthetic
joint infection (PJIs) [1]. Diagnostic procedures include per-
cutaneous aspiration of joint fluid as well as revision sur-
gery with retention or removal of prosthetic elements.
Chronic foreign body-related infections pose a special chal-
lenge because of the diversity of microorganisms involved
and their adaption to a subdued lifestyle associated with
formation of biofilms. Culturing of multiple samples has
been shown to increase diagnostic accuracy, and there is
growing evidence to support the utility of new preparatory
techniques and molecular methods [2-4].
As a direct consequence of this development the number
and types of samples wanted from the surgical field are in-
creasing, and the sampling procedure thereby becomes
more cumbersome for the surgeon. Even with assistance
from a skilled nurse on the floor of the operating theatre
important samples can be missed or deposited in an unsuit-
able transport medium, and the diagnostic accuracy can
thereby be compromised [2,4-6].
Within an ongoing research project comprising patients
with a painful prosthetic joint (‘Prosthesis: Related Infection
and Pain’ (PRIS), www.joint-prosthesis-infection-pain.dk)
we have addressed this issue by designing pre-packed boxes
containing disposable scalpels and forceps, swaps, transport
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vials, and labels needed for sampling during the surgical
procedure. Additional boxes were made available for sam-
ples of synovial fluid obtained by percutaneous joint aspir-
ation. Our primary aim was to overcome the variation in
sampling technique within and between surgical teams and
across difference hospitals, which otherwise might affect
the validity of our clinical study. Our belief was that stream-
lining sampling procedures would maximize the complete-
ness of sample sets. We here present the results from a
2-year project period.
All in a box
We applied the ‘All in a box’ concept to two surgical
procedures and report the completeness of sampling
within a prospective cohort of patients undergoing revi-
sion surgery.
The concept was developed jointly by orthopaedic sur-
geons, molecular biologists, and clinical microbiologists
within the framework of the PRIS project. The project was
approved by the Regional Committee on Health Research
Ethics (June 2011; ref. no. N-20110022). Informed oral and
written consent was obtained from each patient.
The sample repertoire was supplementary to five intraop-
erative soft tissue biopsies obtained according to the
Kamme and Lindberg principle [7]. For revisions the non-
standard samples comprised joint fluid, intraoperative soft
tissue and bone biopsies, swabs from the surface of the
prosthesis in situ, and prosthetic components or the entire
prosthesis. Diagnostic methods included bacteriological cul-
ture, 16S rDNA gene amplification followed by amplicon
sequencing, and fluorescence in situ hybridization (FISH).
Thus, samples were obtained in triplicate except for the
prosthesis itself or prosthetic components. Each sample
was handled separately with disposable utensils in order to
minimize cross-contamination [7,8] and thus allow valid
comparison of different sample types and analyses.
The two types of boxes are presented in Figure 1 and
Table 1. The sample collecting kit for revision surgery
consisted of scalpels and forceps, and a special needle
for a bone biopsy (Vertebroplasty Needle, Synthes, West
Chester PA, USA). Sample tubes were colour coded ac-
cording to sample type. For collection of biopsies, tubes
with a broad neck were chosen to facilitate handling in
the operating theatre as well as in the laboratories. A
sterile container of an appropriate size for the prosthetic
component was included for revision surgery. The only
item not included in the pre-packed boxes was a blood
culture vial for synovial fluid due to its limited shelf life.
From the surgical theatre the boxes were transported at
ambient temperature to the Department of Clinical Micro-
biology and processed within 24 h. Most samples were
processed within 2 h after removal of the prosthesis,
whereas samples from acute surgery undertaken out of
hours were kept at 4°C overnight except for the blood cul-
ture vial that was held at room temperature. When deliv-
ered to the lab, samples for molecular analysis were
subjected to vigorous agitation (vortexing for 30 sec) and
stored immediately at −80°C until batch wise processing
and analysis. For microbiological culture components of
the prosthesis (covered with PBS-buffer, pH7.4) were vor-
texed and sonicated (summarised in [2]). Bone biopsies
were treated similarly before culturing. The joint fluid, tis-
sue biopsies, and the prosthesis swab were cultured without
pre-processing. All sample types were cultured aerobically
and anaerobically for 14 days with subcultivation from en-
richment broth after 6 days for positive samples and after
10 days for negative samples.
All surgeons undertaking revision surgery were in-
formed about the box design and agreed to the concept.
The implementation benefitted further from liaison with
the nurses assisting in the operating theatre. Of note, joint
punctures took place in both ambulatory and in-hospital
Figure 1 Sample boxes for joint puncture (A) and revision surgery (B). A: Joint fluid is both inoculated directly into a blood culture flask
(BacT/Alert, bioMérieux, Marcy l’Etoil, France) and submitted for extensive culture examination and molecular diagnostics. B: Sample tubes are
colour coded in the revision surgery box in order to assist the operation staff in achieving complete sample sets. Sample tubes had a broad neck
in order to facilitate the deposition of the sample.
Larsen et al. BMC Research Notes 2014, 7:418 Page 2 of 4
http://www.biomedcentral.com/1756-0500/7/418
settings, and they were less rigidly standardized compared
with revisions.
‘Proof of concept’
The scheduled number of samples was four for percu-
taneous joint aspiration (box A) and 13 for revision sur-
gery (box B) (Table 1). From December 2011 through
February 2014 we obtained 98 boxes with a complete
sample set out of 164 consecutive boxes (box A: 25/42
(60%); box B: 73/122 (60%)). In all, 1508 of 1685 sched-
uled samples were obtained (overall completeness 89%).
The main reasons for missing samples were deviations
from the pre-planned surgical procedure for clinical rea-
sons or absence of a trained assistant. In 8 cases the
sample set in box B was incomplete as a consequence of
acute surgery (69 of 104 scheduled samples (66%)).
Experience and perspective
We find the ‘All in a box’ to be a promising logistic con-
cept for obtaining multiple samples as part of surgical
procedures. The concept may be applicable not only to
the diagnosis of PJIs but also to other diagnostic proce-
dures and would be well suited especially in circum-
stances where limited amounts of sample material must
be shared between several diagnostic tests and the use of
a correct transport medium plays an important role for
the performance of the diagnostic test. An obvious
addition to the different microbiological tests in this
clinical study would be tissue samples for histopath-
ology. Despite the complex intraoperative sampling pro-
cedure the ‘All in a box’ concept provided an overall
completeness around 90% in a research project involving
several orthopaedic surgeons, numerous nurses, and dif-
ferent hospital premises.
The concept should also be applicable to other com-
plex sampling procedures utilizing a standardized panel
of diagnostic sample types and thus has a potential for
time saving and optimization in different diagnostic set-
tings. Although we ascribe the high level of complete-
ness in our study to the ‘All in a box’ concept, it must be
acknowledged that enthusiasm surrounding the research
project may also have been involved. Still, the positive
attitude often withers when procedures are complicated
and involve many surgeons and nurses, but it was our
impression that the box logistics helped to maintain the
spirit in this case. A drawback to the concept was the
time consumed by the meticulous preparation of the
boxes, a task which can be managed within the frame-
work of a scientific project, but may be difficult to tackle
on a routine basis in hospitals and clinics. We estimate
the cost of materials for box A to be 130 €, and the full
diagnostic work-up of samples in this box may amount
to 1075 € including extensive 16S rDNA sequencing. Im-
plementation of only the most effective diagnostic mo-
dalities may help to decrease these costs. Moreover, the
concept could be of interest to providers of diagnostic
utensils and could also be instrumental in implementing
standardized sampling procedures eventually based on
international guidelines.
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2005 
Contact to the hospital with se-
vere pain, instable TKA. Diagnostic 
imaging revealed synovitis deemed to be 
related to ongoing rheumatologic disease. A 
revision was carried with replacement of both 
the tibia and femur components combined with 
synovectomy. 
The patella component was retained.  
Peroperative specimens revealed coagu-
lase-negative staphylococci in 3 out of 5 
synovial biopsies and the patient was 
put on treatment with 
antibiotics.
2006 
After the revision 
the patient had recur-
rent stress-related pain in the 
proximal tibia, swelling of the 
knee and a slight, but persistent 
elevation of in ammatory markers. 
Repeated joint aspirations were 
negative on standard (aerobic 
&anaerobic culture. The pa-
tient was treated with a brief 
course of glucocorti-
costeroids.  
2012
The patient had per-
sistent stress-related pain in the 
proximal tibia and swelling of the knee. 
The patient was included in the PRIS project 
(www.joint-prosthesis-infection-pain.dk) and 
advanced diagnostic hybrid imaging (bone scan, 
dual leukocyte/bone marrow SPECT-CT and PET-CT) 
showed a ‘hotspot’ at the interface between the lateral 
tibia plateau and the prosthesis. The TKA was removed 
and submitted to extensive microbiological diagnostics 
that included ultrasonication of the prosthetic compo-
nent. The microbiology showed Staphylococcus epider-
midis with an antibiogram similar to that reported in 
2 5, making it very likely that a chronic bio lm 
prosthesis infection had persistent for the last 7 
years. The patient was treated with antibi-
otics and the infections parameter was 
normalised for the rst time since 
1994.
Day 14 
Enrichment broth culture of synovial tissue and 
joint uid were positive for S. epidermidis (prosthe-
sis, tissue, joint uid) and Propionibacterium acnes 
(prosthesis only  CFUs were insigni cant). 
Day 0 
Revision surgery 
Removal of the prosthesis, 
spacer were inserted 
  
Day 6
Cultures of sonication buffer from the prosthesis 
components revealed S. epidermidis  app. 4.5x104 
CFU/prosthesis with an antibiogram distinctly sim-
ilar to that reported in 2005.
2 Months 
A new prosthesis was inserted. In ammatory markers were normalised for the rst time since 1994. If microbiological cultures had not 
been incubated for 14 days, there is a de nite risk that the S. epidermidis infection had been missed again, and the new prosthesis would 
have been inserted before the infection might have been cleared. 
Acknowledgement
This study is part of the Danish ´Prosthetic-Related Infection and Pain´ Innovation Project (Danish acronym PRIS), supported by a grant 
from the Danish Agency for Science, Technology and Innovation, Danish Ministry of Science, Innovation and Higher Education. 
www.joint-prosthesis-infection-pain.dk
1994
Primary prosthesis: 
total knee replacement 
(TKA) with an uncemented 
prosthesis, followed shortly 
by an insertion of a 
cemented patella 
component.
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e
 D
a
n
ish
 ´
Pr
o
st
h
e
tic
-R
e
la
te
d
 In
fe
c
tio
n
 a
n
d
 P
a
in
´ 
In
n
o
va
tio
n
 P
ro
je
c
t 
(D
a
n
ish
 a
c
ro
n
ym
 P
R
IS
) 
a
n
d
 s
u
p
p
o
rt
e
d
 b
y 
Th
e
 D
a
n
ish
 
C
o
u
n
c
il 
fo
r T
e
c
h
n
o
lo
g
y 
a
n
d
 In
n
o
va
tio
n
 (
n
o
. 0
9-
05
21
74
).
  w
w
w
.jo
in
t-
p
ro
st
he
si
s-
in
fe
c
tio
n-
p
a
in
.d
k 
M
e
th
o
d
s:
 
P
a
ra
lle
l 
sa
m
p
lin
g
 
fo
r 
b
o
th
 
c
u
ltu
re
-d
e
p
e
n
d
e
n
t 
a
n
d
 
-
in
d
e
p
e
n
d
e
n
t 
a
n
a
ly
se
s 
w
e
re
 
d
o
n
e
 
o
ve
r 
a
 
p
e
rio
d
 
o
f 
tw
o
 
ye
a
rs
. 
Sp
e
c
im
e
n
s 
in
c
lu
d
e
d
 
tis
su
e
 
b
io
p
sie
s,
 
b
o
n
e
 
b
io
p
sie
s,
 
jo
in
t 
flu
id
, 
a
n
d
 
e
Sw
a
b
s™
 (
C
o
p
a
n
, 
Ita
ly
) 
ta
ke
n
 f
ro
m
 t
h
e
 p
ro
st
h
e
sis
 i
n
 s
itu
, 
a
s 
w
e
ll 
a
s 
so
n
ic
a
tio
n
 f
lu
id
 (
if 
p
ro
st
h
e
sis
 c
o
m
p
o
n
e
n
ts
 w
e
re
 r
e
m
o
ve
d
).
 T
ra
n
sf
e
r 
to
 
th
e
 
la
b
o
ra
to
ry
 
w
a
s 
d
ire
c
t 
(a
m
b
ie
n
t 
te
m
p
e
ra
tu
re
) 
a
n
d
 
st
o
ra
g
e
 
te
m
p
e
ra
tu
re
 f
o
r 
c
u
ltu
re
 s
p
e
c
im
e
n
s 
w
a
s 
+
4°
C
 (
m
a
x 
24
 h
),
 a
n
d
 -
80
°C
 f
o
r 
sp
e
c
im
e
n
s 
fo
r c
u
ltu
re
-in
d
e
p
e
n
d
e
n
t 
m
e
th
o
d
s 
(u
n
til
 b
a
tc
h
w
ise
 a
n
a
ly
sis
).
 
Sp
e
c
im
e
n
s 
fo
r 
p
e
p
tid
e
 n
u
c
le
ic
 a
c
id
-f
lu
o
re
sc
e
n
c
e
 i
n
 s
itu
 h
yb
rid
iz
a
tio
n
 
(P
N
A
-F
IS
H
) 
a
n
a
ly
sis
 w
e
re
 s
to
re
d
 i
n
 C
yM
o
l®
 m
e
d
iu
m
 (
C
o
p
a
n
, 
Ita
ly
) 
fo
r 
u
p
 
to
 
o
n
e
 
ye
a
r. 
D
ire
c
t 
vi
su
a
liz
a
tio
n
 
o
f 
m
ic
ro
o
rg
a
n
ism
s 
fo
llo
w
e
d
 
a
 
p
re
vi
o
u
sly
 p
u
b
lis
h
e
d
 P
N
A
-F
IS
H
®
 (
A
d
va
n
D
x,
 U
SA
) 
p
ro
to
c
o
l e
xc
e
p
t 
fo
r 
a
 
su
b
st
itu
tio
n
 o
f 
th
e
 f
ix
a
tio
n
 s
te
p
 w
ith
 f
ilt
ra
tio
n
 o
f 
20
0 
L 
sa
m
p
le
 t
h
ro
u
g
h
 
a
 
0.
22
 
m
 
w
h
ite
 
p
o
ly
c
a
rb
o
n
a
te
 
fil
te
r 
(p
re
w
a
sh
e
d
 
w
ith
 
d
H
2O
, 
G
E 
W
a
te
r 
&
 P
ro
c
e
ss
 T
e
c
h
n
o
lo
g
ie
s,
 U
SA
) 
in
 o
rd
e
r 
to
 f
ix
 a
n
d
 c
o
n
c
e
n
tr
a
te
 
th
e
 s
a
m
p
le
.  
Re
su
lts
: 
W
ith
 
b
ro
a
d
 
ra
n
g
e
 
a
n
d
 
sp
e
c
ifi
c
 
P
N
A
-F
IS
H
®
 
p
ro
b
e
s,
 
w
e
 
d
e
m
o
n
st
ra
te
d
 
b
a
c
te
ria
 
w
it
h
 
a
 
b
rig
h
t 
si
g
n
a
l 
a
n
d
 
m
o
rp
h
o
lo
g
y 
c
o
m
p
a
ra
b
le
 t
o
 t
h
e
 is
o
la
te
s 
o
b
ta
in
e
d
 b
y 
c
u
ltu
re
 o
f 
p
a
ra
lle
l s
p
e
c
im
e
n
s 
w
ith
in
 
24
 
h
. 
Th
e
 
d
e
te
c
tio
n
 
lim
it 
fo
r 
PN
A
-F
IS
H
®
 
w
e
re
 
>
10
^
2 
C
FU
/m
L 
(e
st
im
a
te
d
 
fr
o
m
 
th
e
 
c
o
lo
n
y 
fo
rm
in
g
 
u
n
its
 
c
u
ltu
re
d
, 
u
p
d
a
te
d
 
fr
o
m
 
a
b
st
ra
c
t)
. 
W
ith
 t
h
e
 e
Sw
a
b
™
 s
ys
te
m
 w
e
 d
e
te
c
te
d
 a
 b
ro
a
d
 r
a
n
g
e
 o
f 
G
ra
m
-p
o
sit
iv
e
 
ta
xa
 
in
c
lu
d
in
g
 
St
a
p
h
yl
o
c
o
c
c
u
s 
sp
p
., 
St
re
p
to
c
o
c
c
u
s 
sp
p
., 
En
te
ro
c
o
c
c
u
s 
sp
p
., 
a
n
d
 C
o
ry
n
e
b
a
c
te
riu
m
 s
p
p
. 
b
y 
c
u
ltu
re
 a
n
d
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N
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n
e
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o
n
 s
e
q
u
e
n
c
in
g
 (
ta
b
le
 1
).
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p
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m
p
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a
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-8
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C
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u
d
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b
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PN
A
-F
IS
H
®
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a
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a
st
 
12
 
m
o
n
th
s 
a
n
d
 w
e
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xp
e
c
t 
st
o
ra
g
e
 f
o
r 
e
ve
n
 lo
n
g
e
r 
p
e
rio
d
s 
to
 b
e
 f
e
a
sib
le
. 
W
e
 e
st
im
a
te
d
 t
h
e
 e
ff
e
c
tiv
e
 d
e
te
c
tio
n
 li
m
it 
to
 b
e
 in
 t
h
e
 o
rd
e
r 
o
f 
>
10
^
2 
C
FU
/m
L 
(u
p
d
a
te
d
 
fr
o
m
 
th
e
 
a
b
st
ra
c
t)
. 
Bo
th
 
th
e
 
m
o
rp
h
o
lo
g
y 
a
n
d
 
in
te
n
sit
y 
o
f 
st
a
in
in
g
 w
ith
 n
u
c
le
ic
 a
c
id
 a
n
d
 P
N
A
 p
ro
b
e
s 
w
e
re
 d
ist
in
c
t.
 
Th
e
 e
Sw
a
b
™
 w
a
s 
a
 c
o
n
ve
n
ie
n
t 
sy
st
e
m
 f
o
r 
d
o
c
u
m
e
n
tin
g
 a
 b
ro
a
d
 
ra
n
g
e
 o
f b
a
c
te
ria
l p
a
th
o
g
e
n
s 
a
ss
o
c
ia
te
d
 w
ith
 fo
re
ig
n
 b
o
d
y 
in
fe
c
tio
n
s.
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t c
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A
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e
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Sw
a
b
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m
o
d
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e
d
 A
m
ie
s 
m
e
d
iu
m
 
 e
Sw
a
b
TM
 s
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re
d
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m
o
d
ifi
e
d
 A
m
ie
s 
m
e
d
iu
m
 w
ith
 2
0%
 
g
ly
c
e
ro
l a
t 
-8
0 
°C
 
St
a
p
h
yl
o
c
o
c
c
u
s 
a
u
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u
s 
+
 
+
 
St
a
p
h
yl
o
c
o
c
c
u
s 
e
p
id
e
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id
is 
+
 
+
 
St
a
p
h
yl
o
c
o
c
c
u
s 
lu
g
d
u
n
e
n
sis
 
+
 
+
 
St
a
p
h
yl
o
c
o
c
c
u
s 
c
a
p
ra
e
 
+
 
+
 
En
te
ro
c
o
c
c
u
s 
fa
e
c
a
lis
 
+
 
St
re
p
to
c
o
c
c
u
s 
d
ys
g
a
la
c
tia
e
 
+
 
+
 
St
re
p
to
c
o
c
c
u
s 
a
g
a
la
c
tia
e
 
+
 
+
 
Pr
o
p
io
n
ib
a
c
te
riu
m
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c
n
e
s 
+
 
+
 
C
o
ry
n
e
b
a
c
te
riu
m
 je
ik
e
iu
m
 
+
 
+
 
C
o
ry
n
e
b
a
c
te
riu
m
 s
tr
ia
tu
m
 
+
 
Es
c
h
e
ric
h
ia
 c
o
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+
 
Ta
b
le
 1
: 
Ba
c
te
ria
l s
p
e
c
ie
s 
re
c
o
ve
re
d
 b
y 
e
Sw
a
b
TM
 (
C
o
p
a
n
, 
Ita
lia
).
 e
Sw
a
b
sT
M
 u
se
d
 f
o
r 
c
u
ltu
rin
g
 w
e
re
 t
ra
n
sp
o
rt
e
d
 i
n
 m
o
d
ifi
e
d
 A
m
ie
s 
m
e
d
iu
m
 a
n
d
 c
u
ltu
re
d
 w
ith
in
 2
4 
h
. 
e
Sw
a
b
sT
M
 f
o
r 
se
q
u
e
n
c
in
g
 w
e
re
 s
to
re
d
 a
t 
-8
0 
°C
 in
 m
o
d
ifi
e
d
 A
m
ie
s 
m
e
d
iu
m
 w
ith
 2
0%
 
g
ly
c
e
ro
l u
n
til
 a
n
a
ly
se
d
 b
a
tc
h
w
ise
.  
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e
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A
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H
®
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n
 s
o
n
ic
a
tio
n
 f
lu
id
 f
ro
m
 h
ip
 p
ro
st
h
e
tic
 c
o
m
p
o
n
e
n
t.
 U
n
iv
e
rs
a
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b
a
c
te
ria
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ro
b
e
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a
c
U
n
i; 
g
re
e
n
, 
En
te
ro
c
o
c
c
u
s 
fa
e
c
a
lis
; 
re
d
. 
Th
e
 
c
u
ltu
re
 
a
n
d
 
se
q
u
e
n
c
in
g
 w
e
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 p
o
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e
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o
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a
e
c
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e
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N
A
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H
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n
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m
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h
e
 c
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q
u
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n
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g
 y
e
llo
w
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a
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 c
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e
rs
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. c
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n
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a
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n
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o
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e
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p
ro
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h
e
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c
o
m
p
o
n
e
n
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St
a
p
h
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o
c
o
c
c
u
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a
u
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u
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g
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e
n
. 
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e
 
c
u
ltu
re
 
a
n
d
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q
u
e
n
c
in
g
 
w
e
re
 
p
o
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e
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r 
S.
 
a
u
re
u
s.
 T
h
e
 P
N
A
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H
 c
o
n
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m
e
d
 t
h
e
 c
u
ltu
rin
g
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n
d
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e
q
u
e
n
c
in
g
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su
lts
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ra
tin
g
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re
e
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b
a
c
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e
g
. c
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n
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a
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n
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h
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 c
o
m
p
o
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n
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a
m
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c
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u
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 S
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p
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u
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u
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e
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 c
u
ltu
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 a
n
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e
q
u
e
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c
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g
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e
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p
o
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e
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o
r 
S.
 a
u
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u
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 T
h
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N
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H
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o
n
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m
e
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h
e
 c
u
ltu
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g
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n
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e
q
u
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g
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su
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g
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e
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a
c
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e
g
. c
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